data_1hjd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hjd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.549 ' N ' HG23 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.448 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.478 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.566 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.453 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.443 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HA ' ' CD ' ' A' ' 43' ' ' ARG . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 14.0 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.473 ' HB3' ' CG1' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.818 0.342 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.407 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.518 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.616 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.417 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.36 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.41 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.414 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.414 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG12 ' CE2' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 22' ' ' ILE . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.545 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.744 0.307 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE2' HG12 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.421 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 82' ' ' SER . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.407 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.537 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 ' CG ' ' A' ' 80' ' ' PHE . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG21 ' CG1' ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' HB ' HG21 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 61' ' ' TRP . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.741 0.305 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CG ' HD12 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 82' ' ' SER . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.49 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 19' ' ' SER . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.554 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 1.5 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.458 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 77' ' ' LEU . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.444 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.442 ' CD1' ' CE1' ' A' ' 31' ' ' TYR . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.402 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 t0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HG21 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.425 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.84 0.353 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.533 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.427 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 86' ' ' ARG . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.431 ' CE1' HG12 ' A' ' 84' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.428 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 41' ' ' ILE . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CZ ' HG13 ' A' ' 47' ' ' VAL . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 31' ' ' TYR . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' N ' ' HB2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.54 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.454 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.4 ' CZ3' ' OE2' ' A' ' 87' ' ' GLU . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' HG11 ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA2' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 80' ' ' PHE . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.861 0.363 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD2' ' HG2' ' A' ' 34' ' ' PRO . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD13 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 HG13 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.442 ' O ' HG11 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.482 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' VAL . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.438 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.406 ' N ' HG11 ' A' ' 26' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 66' ' ' GLN . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 21' ' ' PRO . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 82' ' ' SER . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.598 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.418 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.477 ' CZ ' HG13 ' A' ' 47' ' ' VAL . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.532 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.435 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 64' ' ' SER . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 22' ' ' ILE . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.416 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.52 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.412 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' HG13 ' A' ' 84' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 80' ' ' PHE . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG11 ' C ' ' A' ' 64' ' ' SER . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.534 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.837 0.351 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.514 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.429 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HB ' HG21 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.773 0.32 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.417 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.525 ' N ' HG21 ' A' ' 22' ' ' ILE . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.43 HD13 ' CG ' ' A' ' 80' ' ' PHE . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.425 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 80' ' ' PHE . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.428 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 64' ' ' SER . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.541 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.827 0.346 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.839 0.352 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.474 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.821 0.343 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CD2' HD11 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.44 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' HG13 ' A' ' 46' ' ' VAL . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 84' ' ' ILE . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.447 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.411 ' HA ' ' CA ' ' A' ' 63' ' ' GLY . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.437 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.798 0.333 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.425 ' CZ ' HD13 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.67 96.25 5.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.549 ' N ' HG23 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.448 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.478 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.566 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.82 161.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -150.69 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.676 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -57.9 151.46 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.8 158.54 22.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.77 30.12 62.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -179.93 60.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.059 0.457 . . . . 0.0 110.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.28 174.85 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.64 87.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.068 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.79 164.09 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -96.89 110.74 23.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.453 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -78.89 164.2 24.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.59 163.23 14.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -66.4 -38.56 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -48.09 -78.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.817 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 65.81 81.42 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 139.95 31.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 37' ' ' ARG . 16.4 t80 -166.73 135.7 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 51.2 t 59.05 81.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.87 113.78 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.443 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HA ' ' CD ' ' A' ' 43' ' ' ARG . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 14.0 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.473 ' HB3' ' CG1' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.89 93.93 0.2 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.18 147.07 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -63.06 135.83 57.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 61.13 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.75 35.25 3.3 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.561 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -179.58 60.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -80.17 174.91 11.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.6 86.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.77 115.78 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -159.03 146.17 17.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.6 t -78.87 175.22 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.39 -54.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.823 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -72.76 -173.54 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.666 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -56.67 -16.59 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.059 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.43 36.8 2.58 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.358 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -174.0 78.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.76 20.94 18.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.177 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t 53.22 74.91 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.924 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.811 0.339 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.26 68.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.518 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.616 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.417 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.36 67.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.68 40.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 31.97 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -159.84 154.36 24.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.37 87.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -179.19 60.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.661 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.52 106.58 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 173.93 79.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.97 130.18 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.65 118.23 33.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.701 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.41 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -99.78 109.5 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -170.8 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -140.86 -70.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -53.84 -23.42 12.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.833 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.73 79.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.72 97.4 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -168.84 144.88 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.1 m -60.89 112.87 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.75 90.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.791 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.414 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.414 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG12 ' CE2' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.401 ' HB ' HG21 ' A' ' 22' ' ' ILE . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.545 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . 150.86 70.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.66 125.91 28.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 67' ' ' GLY . 56.7 m-85 -124.19 175.96 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.8 99.27 3.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.09 70.35 1.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.54 60.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.643 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.86 129.24 34.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 174.12 99.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.64 116.71 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.85 138.72 18.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE2' HG12 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 82' ' ' SER . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.407 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.426 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.6 m -80.02 166.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.89 -62.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.685 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -172.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.577 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -61.04 -12.5 11.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.123 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.4 t0 63.15 30.38 16.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.754 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -163.63 137.73 5.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -132.99 98.36 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.86 158.9 1.0 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.757 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.08 98.16 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.537 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.409 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 ' CG ' ' A' ' 80' ' ' PHE . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG21 ' CG1' ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' HB ' HG21 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 61' ' ' TRP . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -138.82 103.9 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.06 165.37 24.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -97.95 54.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.61 35.23 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.86 74.44 1.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 t0 179.61 60.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.672 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.16 104.56 16.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 173.97 66.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.24 139.17 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -141.79 136.89 31.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CG ' HD12 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 82' ' ' SER . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.49 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -79.01 164.59 24.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.79 158.26 5.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.08 -68.53 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.123 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -55.53 -20.97 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.3 -40.09 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.18 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 60.06 171.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.4 163.06 32.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.0 p -171.38 126.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.852 0.358 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -112.21 120.97 43.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 19' ' ' SER . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.554 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.509 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 1.5 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.458 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 77' ' ' LEU . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.444 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.94 45.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -144.1 117.32 8.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -3.83 47.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -145.84 118.24 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.708 0.29 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.1 -133.49 12.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.556 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 178.99 60.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.053 0.454 . . . . 0.0 110.716 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 82.58 0.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 174.21 77.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.2 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -85.39 102.85 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.442 ' CD1' ' CE1' ' A' ' 31' ' ' TYR . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.402 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 163.64 25.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -142.1 -81.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.21 -24.31 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.418 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -49.16 -26.26 2.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 111.948 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.33 69.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.49 111.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.51 98.38 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.07 103.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.935 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -85.79 120.26 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' HG21 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.425 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -137.79 69.14 0.5 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.21 37.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.73 97.83 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.17 117.09 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.91 71.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.435 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 78.73 55.5 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.341 0.591 . . . . 0.0 110.359 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 153.82 20.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.922 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 173.72 73.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 151.92 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -147.68 129.53 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.5 t -78.88 163.89 24.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 177.9 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -76.77 -26.04 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -52.75 -23.06 6.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.958 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -45.83 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 59.34 -169.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.933 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -150.93 117.08 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t 60.09 108.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.774 0.321 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.91 122.43 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.533 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.427 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 86' ' ' ARG . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.431 ' CE1' HG12 ' A' ' 84' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.428 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 41' ' ' ILE . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.52 -79.87 0.33 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.9 132.55 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.782 0.325 . . . . 0.0 110.831 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 73' ' ' LEU . 4.5 m-85 -106.77 53.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 82.56 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.55 50.18 67.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.643 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 179.64 60.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.766 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -105.58 104.1 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.892 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 174.12 77.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.84 165.78 11.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.62 107.84 19.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CZ ' HG13 ' A' ' 47' ' ' VAL . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 31' ' ' TYR . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' N ' ' HB2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t -78.82 168.8 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.73 163.5 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.4 -60.23 2.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -55.02 -21.89 13.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.891 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -72.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.91 108.23 18.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -156.7 145.74 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.52 132.58 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.895 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -90.08 112.26 23.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.54 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.454 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.4 ' CZ3' ' OE2' ' A' ' 87' ' ' GLU . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' HG11 ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.27 -174.19 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.77 -65.66 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.91 -174.33 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 60.77 80.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.47 111.99 3.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -178.37 60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.045 0.45 . . . . 0.0 110.733 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 tt 56.68 111.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.372 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.19 73.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.056 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.84 109.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 116.04 31.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA2' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 80' ' ' PHE . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -84.01 151.25 25.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -137.53 70.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 66.47 13.3 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.551 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -60.52 -19.83 58.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.79 0.329 . . . . 0.0 111.747 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -168.97 92.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.29 -57.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -111.91 156.43 22.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 148.77 40.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.842 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.24 109.82 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.425 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.23 -152.76 7.07 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.48 -47.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -174.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 89.75 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.76 73.16 0.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.82 60.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.15 106.15 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.948 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.39 73.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.96 170.26 9.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -110.64 105.93 15.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 99.1 m -110.17 162.27 14.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 176.59 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -96.83 -33.57 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -55.01 -22.01 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.861 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.72 -69.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.46 142.91 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -142.96 128.95 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.96 154.48 18.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.809 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -171.97 -43.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD2' ' HG2' ' A' ' 34' ' ' PRO . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD13 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 HG13 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.442 ' O ' HG11 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.482 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.83 107.11 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -84.13 179.42 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.78 30.73 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.46 59.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.83 80.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -177.86 59.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.49 179.26 5.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.03 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.17 120.67 40.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -99.09 101.77 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -78.86 173.13 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -71.73 -174.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -74.29 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -53.8 -23.52 12.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.863 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.71 35.28 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.974 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 59.32 170.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.38 119.87 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 87.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -147.06 82.14 1.55 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' VAL . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' CB ' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' A' ' 50' ' ' PHE . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.438 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' N ' HG11 ' A' ' 26' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 66' ' ' GLN . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 21' ' ' PRO . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' CD2' ' HB3' ' A' ' 82' ' ' SER . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.598 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.418 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.97 78.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.51 -42.33 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.05 148.54 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 60.29 176.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.2 128.93 14.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t0 179.83 60.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 110.776 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.53 141.89 37.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.926 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.07 80.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.087 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.76 162.67 18.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -119.73 123.08 42.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.477 ' CZ ' HG13 ' A' ' 47' ' ' VAL . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.8 m -91.28 143.16 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -157.21 33.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -176.55 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -51.6 -25.25 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -96.48 46.86 1.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.808 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.36 156.75 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.72 146.35 51.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.7 t -61.14 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -136.28 106.09 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.987 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.532 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.435 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 64' ' ' SER . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 22' ' ' ILE . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.416 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.52 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.91 -78.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.58 179.72 3.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -113.95 32.31 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -118.55 108.52 15.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.29 -120.04 21.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.34 60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 110.747 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.0 76.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.47 75.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.4 161.04 16.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -100.14 105.99 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.412 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -78.78 163.24 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.84 -71.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -127.54 5.85 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.354 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -54.56 -23.5 17.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.723 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.58 75.57 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.46 130.98 35.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.24 100.05 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 p -60.09 125.43 23.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.763 0.315 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -106.01 120.79 42.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' HG13 ' A' ' 84' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 80' ' ' PHE . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG11 ' C ' ' A' ' 64' ' ' SER . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.534 ' C ' HG11 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.85 -159.94 23.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -104.96 174.63 5.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -143.44 30.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -171.05 118.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.23 77.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.28 60.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.097 0.475 . . . . 0.0 110.637 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.07 128.71 34.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 173.57 74.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.6 158.74 43.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.16 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -160.17 149.33 17.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.768 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t -79.04 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.58 172.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -78.75 -73.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.3 -23.7 9.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.928 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.36 81.19 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 t80 60.84 162.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 179.61 7.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 60.97 112.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.912 0.387 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.31 112.16 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.514 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.429 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HB ' HG21 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.51 28.23 2.57 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.0 87.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -65.43 162.67 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -61.48 131.84 51.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.15 -103.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.492 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 79.01 55.71 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.251 0.548 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.78 97.1 5.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.06 74.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.69 118.14 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.049 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 150.57 16.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.417 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m -85.8 123.01 30.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.55 37.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.86 -59.14 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.47 -24.02 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.809 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 t70 61.76 85.06 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.978 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.82 83.34 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.39 134.01 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.89 161.31 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.92 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.09 66.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.525 ' N ' HG21 ' A' ' 22' ' ' ILE . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.43 HD13 ' CG ' ' A' ' 80' ' ' PHE . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.425 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.72 -179.78 43.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.3 -49.36 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.46 162.0 13.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.31 140.92 35.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.94 42.82 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -177.77 59.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.22 176.7 2.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.61 85.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 152.5 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 96.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.434 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 80' ' ' PHE . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t -79.04 148.37 32.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -178.76 37.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -129.2 -45.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -53.63 -23.95 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.786 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.66 94.17 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.17 129.95 46.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.69 171.99 14.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -174.88 92.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.828 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -103.15 112.04 24.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 94' ' ' GLY . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.428 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 64' ' ' SER . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.541 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.73 107.36 0.32 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -105.73 -55.05 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.52 121.11 27.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.51 155.87 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 72' ' ' ASP . . . -139.86 35.59 1.91 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 54.2 m-20 74.07 53.75 0.1 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.41 0.624 . . . . 0.0 110.283 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.1 tp 55.86 110.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.371 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.84 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.029 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -168.51 132.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -164.54 148.87 9.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 151.15 31.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.99 145.59 31.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -46.16 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -54.47 -22.6 13.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.837 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.95 -52.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -103.54 117.57 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -151.55 111.27 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 123.58 17.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.855 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -105.22 103.99 13.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.474 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.43 94.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.03 117.9 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -170.42 166.96 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.55 30.29 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.17 95.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.402 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 79.04 55.84 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.317 0.579 . . . . 0.0 110.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 tt -80.33 153.88 28.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 177.23 83.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.36 107.24 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 94.89 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -79.11 179.32 7.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -103.35 93.94 5.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.31 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.56 -162.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.108 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -57.9 -15.18 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t70 73.51 4.03 4.69 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 175.43 122.85 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.799 0.333 . . . . 0.0 110.749 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -93.7 129.44 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 96.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.809 0.338 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.6 48.36 4.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CD2' HD11 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.44 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.429 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' HG13 ' A' ' 46' ' ' VAL . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.74 51.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.64 103.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.357 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -163.12 133.19 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.8 137.43 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.96 34.57 17.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -179.82 60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -93.31 119.21 32.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 176.59 95.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.47 146.45 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -149.58 138.11 20.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 84' ' ' ILE . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 91' ' ' LEU . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -78.97 165.48 23.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -126.45 -71.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.231 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.26 -27.99 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -54.96 -21.2 10.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.886 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -50.21 -29.62 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.219 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.25 94.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -75.2 105.23 6.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.1 96.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -118.31 82.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.447 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.411 ' HA ' ' CA ' ' A' ' 63' ' ' GLY . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.437 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.18 39.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -58.52 -176.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.367 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.1 t80 62.15 115.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.14 167.37 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.39 6.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 179.47 60.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.73 115.91 10.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.932 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 174.0 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.17 158.1 20.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.58 127.54 6.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' CZ ' HD13 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.88 158.73 28.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.7 -178.53 7.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -59.44 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.64 -23.62 11.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.802 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.52 65.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -88.58 98.0 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -134.09 167.57 20.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.04 118.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.89 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.887 ' HB3' HD11 ' A' ' 53' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HG2' ' A' ' 99' ' ' LYS . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.675 ' CG ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.714 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.714 ' N ' HG22 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 39' ' ' LEU . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' C ' ' HB2' ' A' ' 33' ' ' ALA . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.755 HD11 ' CD2' ' A' ' 80' ' ' PHE . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 27' ' ' ALA . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 52' ' ' LYS . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' CG ' HG11 ' A' ' 49' ' ' VAL . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 9' ' ' ASP . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CD2' HD11 ' A' ' 41' ' ' ILE . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.682 ' O ' HG22 ' A' ' 84' ' ' ILE . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 81' ' ' PRO . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 27' ' ' ALA . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.618 HG22 ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HE2' HD12 ' A' ' 22' ' ' ILE . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.685 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 53' ' ' LEU . 3.0 m-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.757 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.456 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.844 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HG3' HD11 ' A' ' 84' ' ' ILE . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.403 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.716 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.016 HD11 ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 39.2 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 66' ' ' GLN . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.735 HG13 ' C ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 62' ' ' GLY . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HE3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 9' ' ' ASP . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.735 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.634 ' HB3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.818 0.342 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 1.016 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 41' ' ' ILE . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.61 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 9' ' ' ASP . 10.6 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.809 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 27' ' ' ALA . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 86' ' ' ARG . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.437 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 65' ' ' VAL . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.453 HG22 ' HB1' ' A' ' 27' ' ' ALA . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 62' ' ' GLY . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.452 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.785 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.36 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.611 ' HZ ' HG11 ' A' ' 47' ' ' VAL . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.663 ' O ' HG22 ' A' ' 84' ' ' ILE . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG23 HG13 ' A' ' 85' ' ' VAL . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 84' ' ' ILE . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HD2' HD21 ' A' ' 28' ' ' LEU . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.954 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.561 ' O ' HD23 ' A' ' 12' ' ' LEU . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.853 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.445 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.848 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.445 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.547 HD11 ' CG ' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 62' ' ' GLY . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.817 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.744 0.307 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' GLY . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CG ' HD11 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.853 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' HD21 ' A' ' 53' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' CA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.811 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.568 ' CB ' HG22 ' A' ' 90' ' ' THR . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' A' ' 84' ' ' ILE . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HD2' HD13 ' A' ' 41' ' ' ILE . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' CB ' ' A' ' 38' ' ' PHE . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.571 HD21 HG22 ' A' ' 65' ' ' VAL . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.451 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.699 HD13 ' HD2' ' A' ' 31' ' ' TYR . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD21 ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 60' ' ' PHE . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.65 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.741 0.305 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG2' HD13 ' A' ' 84' ' ' ILE . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 27' ' ' ALA . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.811 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 11' ' ' LYS . 11.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.667 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.407 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.4 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.476 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.686 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 65' ' ' VAL . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 47' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.687 HG13 ' C ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLY . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' A' ' 57' ' ' GLY . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' A' ' 53' ' ' LEU . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.687 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.632 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' HD22 ' A' ' 39' ' ' LEU . 65.0 mtm-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 41' ' ' ILE . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.904 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.667 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.714 ' O ' HD23 ' A' ' 12' ' ' LEU . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 53' ' ' LEU . 20.3 t0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB3' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD1' HG21 ' A' ' 96' ' ' VAL . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.766 HD13 ' HG3' ' A' ' 86' ' ' ARG . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HD2' HD12 ' A' ' 41' ' ' ILE . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.71 ' CD1' HG21 ' A' ' 84' ' ' ILE . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD3' ' CZ3' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' OD1' ' A' ' 9' ' ' ASP . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.462 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.54 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.84 0.353 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CD1' HD11 ' A' ' 41' ' ' ILE . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 84' ' ' ILE . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.462 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 27' ' ' ALA . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.766 ' HG3' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.886 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 15' ' ' ASP . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 9' ' ' ASP . 11.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 90' ' ' THR . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.44 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 27' ' ' ALA . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 28' ' ' LEU . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.758 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' HD12 ' A' ' 41' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 31' ' ' TYR . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG22 HG12 ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 62' ' ' GLY . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 58' ' ' ARG . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.575 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD23 ' OG ' ' A' ' 64' ' ' SER . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 84' ' ' ILE . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 29' ' ' GLN . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' CD ' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.631 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.866 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' A' ' 91' ' ' LEU . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.677 ' OG ' HG22 ' A' ' 90' ' ' THR . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.519 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.757 ' HD2' HD13 ' A' ' 41' ' ' ILE . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.466 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 65' ' ' VAL . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.613 HG21 ' HE3' ' A' ' 61' ' ' TRP . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' HD11 ' A' ' 12' ' ' LEU . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD13 ' HG3' ' A' ' 81' ' ' PRO . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.613 ' HE3' HG21 ' A' ' 49' ' ' VAL . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.714 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HG3' HD13 ' A' ' 59' ' ' LEU . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.617 HG23 HG13 ' A' ' 85' ' ' VAL . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 84' ' ' ILE . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.677 HG22 ' OG ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.866 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.861 0.363 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.436 ' CE ' HG11 ' A' ' 46' ' ' VAL . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.902 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 86' ' ' ARG . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.649 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD23 ' CG2' ' A' ' 65' ' ' VAL . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 80' ' ' PHE . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 ' CG1' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.681 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.609 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 41' ' ' ILE . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 85' ' ' VAL . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 27' ' ' ALA . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.645 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HD2' HD12 ' A' ' 41' ' ' ILE . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.479 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 40' ' ' THR . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 39' ' ' LEU . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.707 HD11 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 13.7 t-80 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HD13 ' A' ' 12' ' ' LEU . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD3' HD11 ' A' ' 12' ' ' LEU . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.602 ' CE3' HG11 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.707 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.625 ' O ' HG22 ' A' ' 84' ' ' ILE . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 27' ' ' ALA . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.645 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.735 ' HE3' HD12 ' A' ' 53' ' ' LEU . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.783 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.452 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.568 ' HG3' HD11 ' A' ' 84' ' ' ILE . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD12 ' A' ' 41' ' ' ILE . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 65' ' ' VAL . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 84' ' ' ILE . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 26' ' ' VAL . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.48 HG11 ' CE3' ' A' ' 61' ' ' TRP . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 77' ' ' LEU . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.735 HD12 ' HE3' ' A' ' 11' ' ' LYS . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.48 ' CE3' HG11 ' A' ' 49' ' ' VAL . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.452 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.676 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' A' ' 41' ' ' ILE . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.898 ' O ' HG22 ' A' ' 84' ' ' ILE . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 27' ' ' ALA . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.758 ' HB2' HD23 ' A' ' 28' ' ' LEU . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.674 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.726 ' CB ' HG22 ' A' ' 90' ' ' THR . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 27' ' ' ALA . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' ARG . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB3' HG21 ' A' ' 84' ' ' ILE . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.706 HD11 ' CE2' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 47' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.814 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 31' ' ' TYR . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 27' ' ' ALA . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 28' ' ' LEU . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.726 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.875 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.874 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.453 ' CE ' HG11 ' A' ' 46' ' ' VAL . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.85 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 86' ' ' ARG . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.76 ' HD2' HD13 ' A' ' 41' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.402 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 65' ' ' VAL . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 31' ' ' TYR . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 62' ' ' GLY . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' A' ' 100' ' ' THR . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.777 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.837 0.351 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' LEU . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.557 HG22 ' OG ' ' A' ' 23' ' ' SER . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.874 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 53' ' ' LEU . 11.3 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' OD1' HG21 ' A' ' 96' ' ' VAL . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.459 ' CE ' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' ILE . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.879 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.651 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.773 0.32 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.79 HD12 ' OG ' ' A' ' 64' ' ' SER . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.695 ' CD2' HD11 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HB2' HD12 ' A' ' 84' ' ' ILE . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 81' ' ' PRO . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 80' ' ' PHE . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.444 HG21 ' OD1' ' A' ' 15' ' ' ASP . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 90' ' ' THR . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.802 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.945 HD21 HG22 ' A' ' 65' ' ' VAL . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.513 HG22 ' HB1' ' A' ' 27' ' ' ALA . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.84 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 22' ' ' ILE . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.74 HD13 ' HG3' ' A' ' 81' ' ' PRO . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.441 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.606 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.945 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 41' ' ' ILE . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HG3' HD13 ' A' ' 59' ' ' LEU . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 27' ' ' ALA . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.445 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.779 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.512 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.846 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' HD2' HD12 ' A' ' 41' ' ' ILE . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.592 HD11 HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 47' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.542 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.827 0.346 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 84' ' ' ILE . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 81' ' ' PRO . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.839 0.352 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.6 m-70 -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.506 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.858 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 28' ' ' LEU . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.547 ' HG3' HD11 ' A' ' 84' ' ' ILE . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 84' ' ' ILE . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.453 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 65' ' ' VAL . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.505 HG22 ' HB1' ' A' ' 27' ' ' ALA . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 47' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 53' ' ' LEU . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.821 0.343 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.834 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.754 ' CG ' HD13 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD11 ' CG ' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.92 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.754 HD13 ' CG ' ' A' ' 31' ' ' TYR . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 27' ' ' ALA . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.692 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.664 HD13 ' CE ' ' A' ' 52' ' ' LYS . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.734 ' CB ' HG22 ' A' ' 90' ' ' THR . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.477 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD13 ' HG3' ' A' ' 86' ' ' ARG . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.522 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CD2' HD13 ' A' ' 84' ' ' ILE . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.456 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.761 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD21 ' CG2' ' A' ' 65' ' ' VAL . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.637 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 22' ' ' ILE . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.664 ' CE ' HD13 ' A' ' 12' ' ' LEU . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' O ' HD23 ' A' ' 53' ' ' LEU . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 82' ' ' SER . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.582 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.798 0.333 . . . . 0.0 110.802 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 64' ' ' SER . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.441 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' HD11 ' A' ' 84' ' ' ILE . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.678 HD13 ' CD2' ' A' ' 31' ' ' TYR . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 27' ' ' ALA . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 28' ' ' LEU . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.613 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.734 HG22 ' CB ' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.643 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.887 ' HB3' HD11 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -116.67 96.25 5.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HG2' ' A' ' 99' ' ' LYS . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.675 ' CG ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.714 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.714 ' N ' HG22 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 39' ' ' LEU . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' C ' ' HB2' ' A' ' 33' ' ' ALA . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.755 HD11 ' CD2' ' A' ' 80' ' ' PHE . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 27' ' ' ALA . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 52' ' ' LYS . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' CG ' HG11 ' A' ' 49' ' ' VAL . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 9' ' ' ASP . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.82 161.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -150.69 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.676 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -57.9 151.46 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.8 158.54 22.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.77 30.12 62.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -179.93 60.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.059 0.457 . . . . 0.0 110.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.28 174.85 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.64 87.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.068 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.79 164.09 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -96.89 110.74 23.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CD2' HD11 ' A' ' 41' ' ' ILE . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.682 ' O ' HG22 ' A' ' 84' ' ' ILE . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 81' ' ' PRO . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 27' ' ' ALA . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.618 HG22 ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HE2' HD12 ' A' ' 22' ' ' ILE . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.685 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -78.89 164.2 24.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.59 163.23 14.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -66.4 -38.56 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -48.09 -78.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.817 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 65.81 81.42 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 139.95 31.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 37' ' ' ARG . 16.4 t80 -166.73 135.7 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 51.2 t 59.05 81.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 53' ' ' LEU . 3.0 m-20 -66.87 113.78 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.757 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.456 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.844 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HG3' HD11 ' A' ' 84' ' ' ILE . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.403 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.716 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.016 HD11 ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 39.2 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 66' ' ' GLN . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.735 HG13 ' C ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 62' ' ' GLY . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HE3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 9' ' ' ASP . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.735 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.634 ' HB3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.89 93.93 0.2 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.18 147.07 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -63.06 135.83 57.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 61.13 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.75 35.25 3.3 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.561 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' OD2' ' NE2' ' A' ' 66' ' ' GLN . 5.9 t0 -179.58 60.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 110.716 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 73' ' ' LEU . 3.6 mp -80.17 174.91 11.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.6 86.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.77 115.78 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -159.03 146.17 17.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 1.016 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 41' ' ' ILE . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.61 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 8' ' ' ALA . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 9' ' ' ASP . 10.6 t -78.87 175.22 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.39 -54.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.823 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -72.76 -173.54 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.666 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -56.67 -16.59 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.059 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.43 36.8 2.58 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.358 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -174.0 78.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.76 20.94 18.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.177 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t 53.22 74.91 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.924 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.811 0.339 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.26 68.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.809 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 27' ' ' ALA . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 86' ' ' ARG . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.437 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 65' ' ' VAL . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.453 HG22 ' HB1' ' A' ' 27' ' ' ALA . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 62' ' ' GLY . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.452 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.785 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.36 67.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.68 40.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 31.97 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -159.84 154.36 24.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.37 87.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -179.19 60.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.661 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.4 tt -68.52 106.58 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.93 79.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.97 130.18 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.65 118.23 33.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.701 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.611 ' HZ ' HG11 ' A' ' 47' ' ' VAL . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.663 ' O ' HG22 ' A' ' 84' ' ' ILE . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG23 HG13 ' A' ' 85' ' ' VAL . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 84' ' ' ILE . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HD2' HD21 ' A' ' 28' ' ' LEU . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.954 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.561 ' O ' HD23 ' A' ' 12' ' ' LEU . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -99.78 109.5 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -170.8 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -140.86 -70.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -53.84 -23.42 12.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.833 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.73 79.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.72 97.4 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -168.84 144.88 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.1 m -60.89 112.87 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.75 90.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.791 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.853 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.445 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.848 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.445 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.547 HD11 ' CG ' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 62' ' ' GLY . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.817 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . 150.86 70.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.66 125.91 28.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 67' ' ' GLY . 56.7 m-85 -124.19 175.96 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.8 99.27 3.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.09 70.35 1.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.54 60.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.643 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 2.0 mt -86.86 129.24 34.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.914 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.12 99.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.64 116.71 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.85 138.72 18.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' GLY . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CG ' HD11 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.853 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 104' ' ' ASP . 37.6 m -80.02 166.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 100' ' ' THR . 1.9 m-20 -128.89 -62.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.685 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -172.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.577 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -61.04 -12.5 11.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.123 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.517 ' HB2' HG21 ' A' ' 100' ' ' THR . 31.4 t0 63.15 30.38 16.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.754 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -163.63 137.73 5.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -132.99 98.36 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.86 158.9 1.0 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.757 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' HD21 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -101.08 98.16 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' CA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.811 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.568 ' CB ' HG22 ' A' ' 90' ' ' THR . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' A' ' 84' ' ' ILE . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HD2' HD13 ' A' ' 41' ' ' ILE . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' CB ' ' A' ' 38' ' ' PHE . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.571 HD21 HG22 ' A' ' 65' ' ' VAL . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.451 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.699 HD13 ' HD2' ' A' ' 31' ' ' TYR . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD21 ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 60' ' ' PHE . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.65 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -138.82 103.9 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.06 165.37 24.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -97.95 54.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.61 35.23 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.86 74.44 1.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 t0 179.61 60.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.672 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 14.5 tp -87.16 104.56 16.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.97 66.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.24 139.17 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -141.79 136.89 31.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG2' HD13 ' A' ' 84' ' ' ILE . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 27' ' ' ALA . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.811 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 11' ' ' LYS . 11.6 t -79.01 164.59 24.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.79 158.26 5.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.08 -68.53 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.123 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -55.53 -20.97 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.3 -40.09 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.18 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 60.06 171.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.4 163.06 32.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.0 p -171.38 126.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.705 ' HB1' ' HE2' ' A' ' 99' ' ' LYS . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.852 0.358 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -112.21 120.97 43.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.667 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.407 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.4 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.476 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.686 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 65' ' ' VAL . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 47' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.687 HG13 ' C ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLY . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' A' ' 57' ' ' GLY . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' A' ' 53' ' ' LEU . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.687 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.632 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.94 45.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -144.1 117.32 8.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -3.83 47.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -145.84 118.24 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.708 0.29 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.1 -133.49 12.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.556 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 178.99 60.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.053 0.454 . . . . 0.0 110.716 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -163.42 82.58 0.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.863 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.21 77.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.2 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' HD22 ' A' ' 39' ' ' LEU . 65.0 mtm-85 -85.39 102.85 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 41' ' ' ILE . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.904 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.667 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.714 ' O ' HD23 ' A' ' 12' ' ' LEU . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.705 ' HE2' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 163.64 25.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -142.1 -81.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.21 -24.31 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.418 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -49.16 -26.26 2.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 111.948 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.33 69.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.49 111.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.51 98.38 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.07 103.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.935 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 53' ' ' LEU . 20.3 t0 -85.79 120.26 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB3' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD1' HG21 ' A' ' 96' ' ' VAL . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.766 HD13 ' HG3' ' A' ' 86' ' ' ARG . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HD2' HD12 ' A' ' 41' ' ' ILE . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.71 ' CD1' HG21 ' A' ' 84' ' ' ILE . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD3' ' CZ3' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' OD1' ' A' ' 9' ' ' ASP . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.462 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.54 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -137.79 69.14 0.5 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.21 37.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.73 97.83 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.17 117.09 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.91 71.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.435 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 78.73 55.5 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.341 0.591 . . . . 0.0 110.359 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -60.05 153.82 20.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.922 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.72 73.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 151.92 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -147.68 129.53 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CD1' HD11 ' A' ' 41' ' ' ILE . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 84' ' ' ILE . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.462 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 27' ' ' ALA . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.766 ' HG3' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.886 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 15' ' ' ASP . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 9' ' ' ASP . 11.5 t -78.88 163.89 24.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 177.9 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -76.77 -26.04 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -52.75 -23.06 6.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.958 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -45.83 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 59.34 -169.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.933 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -150.93 117.08 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t 60.09 108.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.774 0.321 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.91 122.43 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 90' ' ' THR . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.44 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 27' ' ' ALA . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 28' ' ' LEU . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.758 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' HD12 ' A' ' 41' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 31' ' ' TYR . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG22 HG12 ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 62' ' ' GLY . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 58' ' ' ARG . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.575 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.52 -79.87 0.33 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.9 132.55 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.782 0.325 . . . . 0.0 110.831 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.77 53.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.81 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 82.56 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.55 50.18 67.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.643 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 179.64 60.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.766 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -105.58 104.1 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.892 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.12 77.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.84 165.78 11.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.62 107.84 19.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD23 ' OG ' ' A' ' 64' ' ' SER . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 84' ' ' ILE . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 29' ' ' GLN . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' CD ' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t -78.82 168.8 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.73 163.5 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.4 -60.23 2.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -55.02 -21.89 13.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.891 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -72.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.91 108.23 18.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -156.7 145.74 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.52 132.58 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.895 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -90.08 112.26 23.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.866 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' A' ' 91' ' ' LEU . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.677 ' OG ' HG22 ' A' ' 90' ' ' THR . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.519 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.757 ' HD2' HD13 ' A' ' 41' ' ' ILE . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.466 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 65' ' ' VAL . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG21 ' HE3' ' A' ' 61' ' ' TRP . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' HD11 ' A' ' 12' ' ' LEU . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD13 ' HG3' ' A' ' 81' ' ' PRO . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.613 ' HE3' HG21 ' A' ' 49' ' ' VAL . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.714 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.27 -174.19 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.77 -65.66 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.91 -174.33 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 60.77 80.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.47 111.99 3.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -178.37 60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.045 0.45 . . . . 0.0 110.733 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.9 tt 56.68 111.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.372 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 178.19 73.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.056 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.84 109.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 116.04 31.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HG3' HD13 ' A' ' 59' ' ' LEU . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.617 HG23 HG13 ' A' ' 85' ' ' VAL . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 84' ' ' ILE . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.677 HG22 ' OG ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.866 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 103' ' ' TRP . 90.0 m -84.01 151.25 25.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -137.53 70.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 66.47 13.3 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.551 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.468 ' HB2' HG23 ' A' ' 100' ' ' THR . 20.9 m95 -60.52 -19.83 58.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.79 0.329 . . . . 0.0 111.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -168.97 92.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.29 -57.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -111.91 156.43 22.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 148.77 40.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.842 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.24 109.82 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD2' ' HB3' ' A' ' 8' ' ' ALA . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.436 ' CE ' HG11 ' A' ' 46' ' ' VAL . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.902 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 86' ' ' ARG . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.649 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD23 ' CG2' ' A' ' 65' ' ' VAL . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 80' ' ' PHE . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 ' CG1' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.681 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.609 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.23 -152.76 7.07 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.48 -47.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -174.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 89.75 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.76 73.16 0.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.82 60.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.15 106.15 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.948 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.39 73.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.96 170.26 9.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -110.64 105.93 15.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 41' ' ' ILE . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 85' ' ' VAL . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 27' ' ' ALA . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 101' ' ' ASP . 99.1 m -110.17 162.27 14.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' THR . 0.4 OUTLIER -110.58 176.59 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -96.83 -33.57 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -55.01 -22.01 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.861 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.72 -69.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.46 142.91 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -142.96 128.95 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.96 154.48 18.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.809 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HA ' HD21 ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -171.97 -43.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.645 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HD2' HD12 ' A' ' 41' ' ' ILE . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.479 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 40' ' ' THR . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 39' ' ' LEU . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.707 HD11 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 13.7 t-80 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HD13 ' A' ' 12' ' ' LEU . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 8' ' ' ALA . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD3' HD11 ' A' ' 12' ' ' LEU . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.602 ' CE3' HG11 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.83 107.11 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -84.13 179.42 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.78 30.73 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.46 59.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.83 80.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -177.86 59.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.49 179.26 5.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.03 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.17 120.67 40.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -99.09 101.77 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.707 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.625 ' O ' HG22 ' A' ' 84' ' ' ILE . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 27' ' ' ALA . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.645 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -78.86 173.13 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -71.73 -174.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -74.29 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -53.8 -23.52 12.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.863 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.71 35.28 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.974 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 59.32 170.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.38 119.87 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 87.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -147.06 82.14 1.55 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.735 ' HE3' HD12 ' A' ' 53' ' ' LEU . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.783 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.452 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.568 ' HG3' HD11 ' A' ' 84' ' ' ILE . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD12 ' A' ' 41' ' ' ILE . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 65' ' ' VAL . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 84' ' ' ILE . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 26' ' ' VAL . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.48 HG11 ' CE3' ' A' ' 61' ' ' TRP . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 77' ' ' LEU . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.735 HD12 ' HE3' ' A' ' 11' ' ' LYS . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.48 ' CE3' HG11 ' A' ' 49' ' ' VAL . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.452 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.676 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.97 78.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.51 -42.33 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.05 148.54 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 60.29 176.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.2 128.93 14.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t0 179.83 60.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 110.776 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.53 141.89 37.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.07 80.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.087 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.76 162.67 18.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -119.73 123.08 42.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' A' ' 41' ' ' ILE . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.898 ' O ' HG22 ' A' ' 84' ' ' ILE . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 27' ' ' ALA . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.758 ' HB2' HD23 ' A' ' 28' ' ' LEU . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.674 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 103' ' ' TRP . 84.8 m -91.28 143.16 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -157.21 33.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -176.55 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.647 ' HB2' HG23 ' A' ' 100' ' ' THR . 16.0 m95 -51.6 -25.25 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.826 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -96.48 46.86 1.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.808 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.36 156.75 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.72 146.35 51.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.7 t -61.14 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -136.28 106.09 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.987 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.726 ' CB ' HG22 ' A' ' 90' ' ' THR . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 27' ' ' ALA . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' ARG . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB3' HG21 ' A' ' 84' ' ' ILE . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.706 HD11 ' CE2' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 47' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.814 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.91 -78.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.58 179.72 3.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -113.95 32.31 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -118.55 108.52 15.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.29 -120.04 21.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.34 60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 110.747 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.0 76.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.47 75.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.4 161.04 16.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -100.14 105.99 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 31' ' ' TYR . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 27' ' ' ALA . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 28' ' ' LEU . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.726 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.875 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -78.78 163.24 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.84 -71.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -127.54 5.85 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.354 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -54.56 -23.5 17.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.723 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.58 75.57 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.46 130.98 35.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.24 100.05 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 p -60.09 125.43 23.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.763 0.315 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -106.01 120.79 42.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.874 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.453 ' CE ' HG11 ' A' ' 46' ' ' VAL . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.85 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 86' ' ' ARG . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.76 ' HD2' HD13 ' A' ' 41' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.402 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 65' ' ' VAL . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 31' ' ' TYR . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 62' ' ' GLY . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' A' ' 100' ' ' THR . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.777 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.85 -159.94 23.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -104.96 174.63 5.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -143.44 30.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -171.05 118.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.23 77.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.28 60.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.097 0.475 . . . . 0.0 110.637 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 1.1 mp -84.07 128.71 34.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.916 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.57 74.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.6 158.74 43.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.16 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -160.17 149.33 17.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.768 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' LEU . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.557 HG22 ' OG ' ' A' ' 23' ' ' SER . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.874 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 53' ' ' LEU . 11.3 t -79.04 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.58 172.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -78.75 -73.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.3 -23.7 9.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.928 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.36 81.19 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 t80 60.84 162.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 179.61 7.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 60.97 112.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.912 0.387 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.31 112.16 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' OD1' HG21 ' A' ' 96' ' ' VAL . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.459 ' CE ' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' ILE . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.879 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.651 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.51 28.23 2.57 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.0 87.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -65.43 162.67 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -61.48 131.84 51.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.15 -103.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.492 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 79.01 55.71 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.251 0.548 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.78 97.1 5.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.06 74.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.69 118.14 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.049 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 150.57 16.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.79 HD12 ' OG ' ' A' ' 64' ' ' SER . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.695 ' CD2' HD11 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HB2' HD12 ' A' ' 84' ' ' ILE . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 81' ' ' PRO . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 80' ' ' PHE . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.444 HG21 ' OD1' ' A' ' 15' ' ' ASP . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m -85.8 123.01 30.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.55 37.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.86 -59.14 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.47 -24.02 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.809 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 t70 61.76 85.06 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.978 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.82 83.34 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.39 134.01 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.89 161.31 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.92 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.09 66.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 90' ' ' THR . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.802 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.945 HD21 HG22 ' A' ' 65' ' ' VAL . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.513 HG22 ' HB1' ' A' ' 27' ' ' ALA . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.84 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 22' ' ' ILE . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.74 HD13 ' HG3' ' A' ' 81' ' ' PRO . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.441 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.606 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.945 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.72 -179.78 43.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.3 -49.36 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.46 162.0 13.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.31 140.92 35.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.94 42.82 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -177.77 59.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.22 176.7 2.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.61 85.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 152.5 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 96.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 41' ' ' ILE . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HG3' HD13 ' A' ' 59' ' ' LEU . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 27' ' ' ALA . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.445 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.779 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t -79.04 148.37 32.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -178.76 37.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -129.2 -45.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -53.63 -23.95 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.786 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.66 94.17 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.17 129.95 46.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.69 171.99 14.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -174.88 92.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.828 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -103.15 112.04 24.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.512 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.846 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' HD2' HD12 ' A' ' 41' ' ' ILE . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.592 HD11 HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 47' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.542 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.73 107.36 0.32 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -105.73 -55.05 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.52 121.11 27.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.51 155.87 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 72' ' ' ASP . . . -139.86 35.59 1.91 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 54.2 m-20 74.07 53.75 0.1 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.41 0.624 . . . . 0.0 110.283 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.1 tp 55.86 110.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.371 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 178.84 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.029 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -168.51 132.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -164.54 148.87 9.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 84' ' ' ILE . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 81' ' ' PRO . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 151.15 31.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.99 145.59 31.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -46.16 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -54.47 -22.6 13.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.837 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.95 -52.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -103.54 117.57 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -151.55 111.27 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 123.58 17.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.855 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -105.22 103.99 13.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.6 m-70 -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.506 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.858 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 28' ' ' LEU . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.547 ' HG3' HD11 ' A' ' 84' ' ' ILE . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 84' ' ' ILE . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.453 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 65' ' ' VAL . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.505 HG22 ' HB1' ' A' ' 27' ' ' ALA . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 47' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 53' ' ' LEU . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.43 94.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.03 117.9 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -170.42 166.96 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.55 30.29 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.17 95.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.402 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 79.04 55.84 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.317 0.579 . . . . 0.0 110.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 74' ' ' ALA . 7.6 tt -80.33 153.88 28.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 73' ' ' LEU . . . 177.23 83.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.36 107.24 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 94.89 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -79.11 179.32 7.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -103.35 93.94 5.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.31 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.56 -162.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.108 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -57.9 -15.18 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t70 73.51 4.03 4.69 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 175.43 122.85 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.799 0.333 . . . . 0.0 110.749 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -93.7 129.44 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 96.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.876 ' HB1' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.809 0.338 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.6 48.36 4.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.834 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.754 ' CG ' HD13 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD11 ' CG ' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.876 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.74 51.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.64 103.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.357 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -163.12 133.19 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.8 137.43 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.96 34.57 17.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -179.82 60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.2 mp -93.31 119.21 32.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 176.59 95.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.47 146.45 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -149.58 138.11 20.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.92 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.754 HD13 ' CG ' ' A' ' 31' ' ' TYR . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 27' ' ' ALA . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.692 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -78.97 165.48 23.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -126.45 -71.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.231 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.26 -27.99 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -54.96 -21.2 10.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.886 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -50.21 -29.62 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.219 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.25 94.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -75.2 105.23 6.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.1 96.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 10' ' ' ARG . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -118.31 82.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 8' ' ' ALA . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.664 HD13 ' CE ' ' A' ' 52' ' ' LYS . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.734 ' CB ' HG22 ' A' ' 90' ' ' THR . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.477 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD13 ' HG3' ' A' ' 86' ' ' ARG . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.522 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CD2' HD13 ' A' ' 84' ' ' ILE . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.456 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.761 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD21 ' CG2' ' A' ' 65' ' ' VAL . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.637 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 22' ' ' ILE . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.664 ' CE ' HD13 ' A' ' 12' ' ' LEU . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' O ' HD23 ' A' ' 53' ' ' LEU . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 82' ' ' SER . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.582 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.18 39.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -58.52 -176.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.367 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.1 t80 62.15 115.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.14 167.37 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.39 6.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 179.47 60.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 tp -70.73 115.91 10.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.0 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.17 158.1 20.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -157.58 127.54 6.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 64' ' ' SER . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.441 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' HD11 ' A' ' 84' ' ' ILE . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.678 HD13 ' CD2' ' A' ' 31' ' ' TYR . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 27' ' ' ALA . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 28' ' ' LEU . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.613 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.734 HG22 ' CB ' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.643 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.88 158.73 28.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.7 -178.53 7.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -59.44 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.64 -23.62 11.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.802 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.52 65.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -88.58 98.0 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -134.09 167.57 20.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.04 118.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.89 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.887 ' HB3' HD11 ' A' ' 53' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HG2' ' A' ' 99' ' ' LYS . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.675 ' CG ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 20' ' ' HIS . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.714 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.714 ' N ' HG22 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 39' ' ' LEU . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' C ' ' HB2' ' A' ' 33' ' ' ALA . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.755 HD11 ' CD2' ' A' ' 80' ' ' PHE . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 27' ' ' ALA . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 52' ' ' LYS . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' CG ' HG11 ' A' ' 49' ' ' VAL . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 9' ' ' ASP . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CD2' HD11 ' A' ' 41' ' ' ILE . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.682 ' O ' HG22 ' A' ' 84' ' ' ILE . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 81' ' ' PRO . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 27' ' ' ALA . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.618 HG22 ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HE2' HD12 ' A' ' 22' ' ' ILE . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.685 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 53' ' ' LEU . 3.0 m-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.839 0.352 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.757 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.456 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.844 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HG3' HD11 ' A' ' 84' ' ' ILE . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.403 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.716 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.016 HD11 ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 14.0 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 66' ' ' GLN . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.735 HG13 ' C ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 62' ' ' GLY . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HE3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 9' ' ' ASP . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.735 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.634 ' HB3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.818 0.342 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 1.016 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 41' ' ' ILE . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.61 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 9' ' ' ASP . 10.6 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.809 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 27' ' ' ALA . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 86' ' ' ARG . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.437 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 65' ' ' VAL . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.453 HG22 ' HB1' ' A' ' 27' ' ' ALA . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 62' ' ' GLY . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.452 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.785 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.36 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.611 ' HZ ' HG11 ' A' ' 47' ' ' VAL . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.663 ' O ' HG22 ' A' ' 84' ' ' ILE . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG23 HG13 ' A' ' 85' ' ' VAL . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 84' ' ' ILE . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HD2' HD21 ' A' ' 28' ' ' LEU . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.954 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.561 ' O ' HD23 ' A' ' 12' ' ' LEU . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.853 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.445 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.848 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.445 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.547 HD11 ' CG ' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 62' ' ' GLY . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.817 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.744 0.307 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' GLY . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CG ' HD11 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.853 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' HD21 ' A' ' 53' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' CA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.811 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.568 ' CB ' HG22 ' A' ' 90' ' ' THR . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' A' ' 84' ' ' ILE . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HD2' HD13 ' A' ' 41' ' ' ILE . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' CB ' ' A' ' 38' ' ' PHE . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.571 HD21 HG22 ' A' ' 65' ' ' VAL . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.451 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.699 HD13 ' HD2' ' A' ' 31' ' ' TYR . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD21 ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 60' ' ' PHE . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.65 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.741 0.305 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG2' HD13 ' A' ' 84' ' ' ILE . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.681 ' O ' HG22 ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 27' ' ' ALA . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.811 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 11' ' ' LYS . 11.6 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.667 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.407 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 1.5 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.476 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.686 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 65' ' ' VAL . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 47' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.687 HG13 ' C ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLY . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' A' ' 57' ' ' GLY . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' A' ' 53' ' ' LEU . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.687 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.632 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' HD22 ' A' ' 39' ' ' LEU . 65.0 mtm-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 41' ' ' ILE . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.904 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.667 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.714 ' O ' HD23 ' A' ' 12' ' ' LEU . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 53' ' ' LEU . 20.3 t0 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB3' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD1' HG21 ' A' ' 96' ' ' VAL . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.766 HD13 ' HG3' ' A' ' 86' ' ' ARG . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HD2' HD12 ' A' ' 41' ' ' ILE . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.71 ' CD1' HG21 ' A' ' 84' ' ' ILE . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HG2' HG12 ' A' ' 65' ' ' VAL . 9.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' OD1' ' A' ' 9' ' ' ASP . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.462 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.54 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.84 0.353 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CD1' HD11 ' A' ' 41' ' ' ILE . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 84' ' ' ILE . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.462 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 27' ' ' ALA . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.766 ' HG3' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.886 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 15' ' ' ASP . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 9' ' ' ASP . 11.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.821 0.343 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 90' ' ' THR . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.44 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 27' ' ' ALA . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.758 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' HD12 ' A' ' 41' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 31' ' ' TYR . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.904 HG22 HG12 ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 62' ' ' GLY . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 58' ' ' ARG . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.575 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD23 ' OG ' ' A' ' 64' ' ' SER . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 84' ' ' ILE . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 29' ' ' GLN . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.631 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.85 0.357 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.866 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' A' ' 91' ' ' LEU . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.677 ' OG ' HG22 ' A' ' 90' ' ' THR . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.519 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.757 ' HD2' HD13 ' A' ' 41' ' ' ILE . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.466 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 65' ' ' VAL . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.613 HG21 ' HE3' ' A' ' 61' ' ' TRP . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' HD11 ' A' ' 12' ' ' LEU . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD13 ' HG3' ' A' ' 81' ' ' PRO . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.613 ' HE3' HG21 ' A' ' 49' ' ' VAL . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.714 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HG3' HD13 ' A' ' 59' ' ' LEU . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.617 HG23 HG13 ' A' ' 85' ' ' VAL . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 84' ' ' ILE . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.677 HG22 ' OG ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.866 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.861 0.363 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.436 ' CE ' HG11 ' A' ' 46' ' ' VAL . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.902 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 86' ' ' ARG . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.649 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD23 ' CG2' ' A' ' 65' ' ' VAL . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 80' ' ' PHE . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 ' CG1' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.681 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.609 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.794 0.33 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 41' ' ' ILE . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 85' ' ' VAL . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 27' ' ' ALA . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.645 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HD2' HD12 ' A' ' 41' ' ' ILE . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.479 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 40' ' ' THR . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 39' ' ' LEU . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.707 HD11 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 1.9 t60 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HD13 ' A' ' 12' ' ' LEU . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD3' HD11 ' A' ' 12' ' ' LEU . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.602 ' CE3' HG11 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.707 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.625 ' O ' HG22 ' A' ' 84' ' ' ILE . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 27' ' ' ALA . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.645 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.735 ' HE3' HD12 ' A' ' 53' ' ' LEU . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.783 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.452 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.568 ' HG3' HD11 ' A' ' 84' ' ' ILE . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD12 ' A' ' 41' ' ' ILE . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 65' ' ' VAL . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 84' ' ' ILE . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 26' ' ' VAL . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.48 HG11 ' CE3' ' A' ' 61' ' ' TRP . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 77' ' ' LEU . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.735 HD12 ' HE3' ' A' ' 11' ' ' LYS . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.48 ' CE3' HG11 ' A' ' 49' ' ' VAL . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.452 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.676 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.86 0.362 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' A' ' 41' ' ' ILE . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.898 ' O ' HG22 ' A' ' 84' ' ' ILE . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 27' ' ' ALA . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.758 ' HB2' HD23 ' A' ' 28' ' ' LEU . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.674 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.726 ' CB ' HG22 ' A' ' 90' ' ' THR . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 27' ' ' ALA . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' ARG . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB3' HG21 ' A' ' 84' ' ' ILE . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.706 HD11 ' CE2' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 47' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.814 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 31' ' ' TYR . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 27' ' ' ALA . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 28' ' ' LEU . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.726 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.875 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.874 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.453 ' CE ' HG11 ' A' ' 46' ' ' VAL . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.85 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 86' ' ' ARG . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.76 ' HD2' HD13 ' A' ' 41' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.402 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 65' ' ' VAL . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 31' ' ' TYR . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 62' ' ' GLY . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' A' ' 100' ' ' THR . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.777 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.837 0.351 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' LEU . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.557 HG22 ' OG ' ' A' ' 23' ' ' SER . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.874 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 53' ' ' LEU . 11.3 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' OD1' HG21 ' A' ' 96' ' ' VAL . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.459 ' CE ' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' ILE . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.879 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.651 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.773 0.32 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.79 HD12 ' OG ' ' A' ' 64' ' ' SER . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.695 ' CD2' HD11 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HB2' HD12 ' A' ' 84' ' ' ILE . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 81' ' ' PRO . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 80' ' ' PHE . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.444 HG21 ' OD1' ' A' ' 15' ' ' ASP . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 90' ' ' THR . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.802 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.945 HD21 HG22 ' A' ' 65' ' ' VAL . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.513 HG22 ' HB1' ' A' ' 27' ' ' ALA . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.514 HE21 HG11 ' A' ' 65' ' ' VAL . 7.8 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.84 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 22' ' ' ILE . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.74 HD13 ' HG3' ' A' ' 81' ' ' PRO . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.441 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.606 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.945 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 41' ' ' ILE . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HG3' HD13 ' A' ' 59' ' ' LEU . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 27' ' ' ALA . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.445 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.779 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.512 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.846 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' HD2' HD12 ' A' ' 41' ' ' ILE . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.592 HD11 HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 47' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.542 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.827 0.346 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 84' ' ' ILE . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 81' ' ' PRO . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.839 0.352 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.506 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.858 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.547 ' HG3' HD11 ' A' ' 84' ' ' ILE . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 84' ' ' ILE . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.453 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 65' ' ' VAL . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.505 HG22 ' HB1' ' A' ' 27' ' ' ALA . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 47' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 53' ' ' LEU . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.821 0.343 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.834 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.754 ' CG ' HD13 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD11 ' CG ' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.92 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.754 HD13 ' CG ' ' A' ' 31' ' ' TYR . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 27' ' ' ALA . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.692 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.664 HD13 ' CE ' ' A' ' 52' ' ' LYS . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.734 ' CB ' HG22 ' A' ' 90' ' ' THR . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.477 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD13 ' HG3' ' A' ' 86' ' ' ARG . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.522 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CD2' HD13 ' A' ' 84' ' ' ILE . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.456 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.761 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD21 ' CG2' ' A' ' 65' ' ' VAL . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.637 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 22' ' ' ILE . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.664 ' CE ' HD13 ' A' ' 12' ' ' LEU . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' O ' HD23 ' A' ' 53' ' ' LEU . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 82' ' ' SER . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.582 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.798 0.333 . . . . 0.0 110.802 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 64' ' ' SER . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.441 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' HD11 ' A' ' 84' ' ' ILE . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.678 HD13 ' CD2' ' A' ' 31' ' ' TYR . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 27' ' ' ALA . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 28' ' ' LEU . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.613 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.734 HG22 ' CB ' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.643 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.887 ' HB3' HD11 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -116.67 96.25 5.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HG2' ' A' ' 99' ' ' LYS . 2.5 mtp180 -98.89 141.37 31.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.675 ' CG ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.54 147.46 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.114 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.36 136.24 33.08 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 122.25 1.024 . . . . 0.0 112.546 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.48 148.94 24.9 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 20' ' ' HIS . . . -87.53 47.11 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.23 -169.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.753 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -93.78 -53.08 4.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -94.02 18.57 10.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.25 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.8 m 56.44 69.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 m -149.74 50.87 0.93 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -166.71 148.28 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 155.2 64.62 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.563 2.175 . . . . 0.0 112.176 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.714 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -85.93 -68.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.196 0.522 . . . . 0.0 111.158 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.714 ' N ' HG22 ' A' ' 22' ' ' ILE . 79.8 p -169.37 -168.8 0.85 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 17.5 ttp -129.46 144.04 51.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.714 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.52 169.07 18.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 111.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 86' ' ' ARG . 47.4 t -118.66 154.09 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -74.17 126.76 31.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.849 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -89.24 -2.97 58.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.567 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.6 pt20 167.6 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 11.9 t70 -78.03 138.31 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.998 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -156.85 83.26 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.49 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -68.92 105.27 2.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.464 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 39' ' ' LEU . . . -40.32 158.59 0.15 Allowed Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.63 -66.17 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.437 2.091 . . . . 0.0 112.302 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 179.81 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.4 t 75.59 -54.0 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.522 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.406 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 3.1 mmt180 -41.58 -31.21 0.26 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.854 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' CE1' ' CE2' ' A' ' 60' ' ' PHE . 70.8 m-85 -144.88 168.9 19.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' C ' ' HB2' ' A' ' 33' ' ' ALA . 2.7 tp -100.82 154.14 18.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 5.1 t -87.38 170.14 11.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.248 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.755 HD11 ' CD2' ' A' ' 80' ' ' PHE . 55.3 mt -147.0 106.65 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t60 -97.19 151.62 19.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 16.9 mmm-85 -46.03 162.22 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.886 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.26 28.63 1.45 Allowed Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.657 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 27' ' ' ALA . 11.4 tt0 -113.93 111.52 21.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 110.406 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 51.9 t -69.79 153.39 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.948 0.404 . . . . 0.0 110.952 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.77 170.16 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.906 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -137.2 101.84 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 52' ' ' LYS . 21.6 t -69.88 136.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -119.11 -25.4 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.93 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.19 116.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' CG ' HG11 ' A' ' 49' ' ' VAL . 2.3 mtmp? -100.86 128.24 46.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 9' ' ' ASP . 4.4 tt -98.64 116.64 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -162.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.953 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.48 18.69 44.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.413 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 167.74 -31.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.791 0.329 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.94 44.06 1.09 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.748 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -52.71 -29.27 25.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.86 -2.54 24.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.907 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -127.95 92.54 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.321 . . . . 0.0 110.79 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 14.3 m0 -90.19 -178.77 5.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.738 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -140.99 133.0 5.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.01 -146.17 7.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.703 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -157.25 153.8 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 157.61 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.688 0.756 . . . . 0.0 110.725 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.32 164.02 19.37 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.995 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.82 161.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.812 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -150.69 83.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.676 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -57.9 151.46 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.8 158.54 22.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.77 30.12 62.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -179.93 60.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.059 0.457 . . . . 0.0 110.739 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.28 174.85 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.64 87.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.068 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.79 164.09 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -96.89 110.74 23.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -62.12 149.85 40.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.36 178.37 20.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.409 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -123.12 129.12 51.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 0.0 110.969 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CD2' HD11 ' A' ' 41' ' ' ILE . 4.3 p90 -159.12 157.4 27.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.682 ' O ' HG22 ' A' ' 84' ' ' ILE . 32.2 Cg_endo -64.02 165.15 19.87 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -33.4 26.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -52.14 -33.73 41.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.366 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 81' ' ' PRO . 5.5 tp -72.08 -9.31 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 27' ' ' ALA . 4.4 m -138.74 179.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.34 . . . . 0.0 111.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -144.19 109.27 5.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 3.7 pm0 -68.74 122.2 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.983 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.45 -48.69 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.8 tt0 -104.8 148.47 26.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.403 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.618 HG22 ' CB ' ' A' ' 23' ' ' SER . 7.0 p -138.09 149.54 46.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.64 33.61 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.364 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HE2' HD12 ' A' ' 22' ' ' ILE . 8.3 ptpt -90.29 106.48 15.02 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 72.7 Cg_endo -75.53 -24.27 12.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.373 2.048 . . . . 0.0 111.702 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -134.13 172.21 21.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.294 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.685 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -151.72 50.62 0.81 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.057 0.455 . . . . 0.0 110.367 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.52 141.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -77.66 149.38 34.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.966 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.9 t -143.69 104.89 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.098 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HG2' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -66.74 134.2 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -78.89 164.2 24.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.59 163.23 14.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -66.4 -38.56 87.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -48.09 -78.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.817 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 65.81 81.42 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.921 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 139.95 31.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 37' ' ' ARG . 16.4 t80 -166.73 135.7 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 51.2 t 59.05 81.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.894 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB3' HD21 ' A' ' 53' ' ' LEU . 3.0 m-20 -66.87 113.78 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.23 157.28 16.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.732 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 98' ' ' VAL . 1.5 pttm -152.81 151.51 30.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.852 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.757 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.2 mp -88.13 142.1 28.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 122.121 0.962 . . . . 0.0 112.546 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.49 46.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.85 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.91 65.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.131 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 2.7 m-20 63.36 -177.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.24 68.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -170.05 -55.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.58 30.43 15.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.071 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.1 m -78.84 -63.54 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.77 151.14 97.08 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.3 151.7 60.49 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.591 2.194 . . . . 0.0 112.375 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -67.71 -46.59 82.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 71.9 p -178.06 -168.07 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.21 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.456 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 9.6 ttp -124.35 142.72 51.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.913 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -141.06 123.39 15.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 16.4 t -87.78 147.44 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.033 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.844 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -79.03 112.9 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 3.4 tp -72.21 -10.21 59.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.665 ' HG3' HD11 ' A' ' 84' ' ' ILE . 1.6 pt20 168.82 173.5 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -60.76 149.51 35.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.652 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -160.9 88.68 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.415 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.403 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.3 ptt? -65.43 130.14 42.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.0 133.38 1.1 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.012 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.96 -48.88 19.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.417 2.078 . . . . 0.0 112.232 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.79 -174.98 2.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.35 19.86 9.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.221 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.54 44.18 30.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.716 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.5 m-85 -68.21 -175.96 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 tp -85.7 120.57 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -82.32 170.06 15.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 111.371 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.016 HD11 ' CE1' ' A' ' 80' ' ' PHE . 57.1 mt -124.99 149.36 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.415 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.96 151.41 52.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 8.7 mmm-85 -43.68 156.95 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.035 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.14 4.97 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.666 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 66' ' ' GLN . 14.0 tt0 -127.04 105.44 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 66' ' ' GLN . 12.5 p -70.67 161.33 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.281 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.735 HG13 ' C ' ' A' ' 64' ' ' SER . 17.1 t -147.2 146.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.88 103.97 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.089 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 62' ' ' GLY . 45.9 t -70.03 135.42 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.1 t -153.69 157.4 39.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.371 . . . . 0.0 111.215 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HE3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.09 81.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.765 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 9' ' ' ASP . 5.3 tt -62.53 130.57 45.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 -154.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.61 -61.34 4.26 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.936 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.07 17.76 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.718 0.294 . . . . 0.0 110.645 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 31.69 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -30.36 10.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.0 111.161 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -3.43 29.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.906 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.32 85.65 2.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -89.69 132.71 35.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -88.17 125.88 7.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.1 -156.4 7.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.904 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.735 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.31 124.62 5.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.98 153.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 121.863 0.839 . . . . 0.0 110.313 -179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.634 ' HB3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -56.84 146.38 26.5 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.149 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.89 93.93 0.2 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.515 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.18 147.07 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -63.06 135.83 57.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 61.13 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.75 35.25 3.3 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.561 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -179.58 60.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 73' ' ' LEU . 3.6 mp -80.17 174.91 11.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.87 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.6 86.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.77 115.78 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -159.03 146.17 17.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -62.58 139.51 58.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.69 172.99 21.4 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.495 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -134.16 109.5 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.779 0.323 . . . . 0.0 110.769 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 1.016 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.7 p90 -159.2 160.66 28.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -49.99 117.44 3.09 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.644 2.229 . . . . 0.0 112.284 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -6.53 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 76.5 p -47.71 -38.0 14.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.794 0.33 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 41' ' ' ILE . 5.9 tp -62.53 -36.25 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.209 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.1 m -98.49 150.51 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.003 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.06 122.19 47.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.723 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.6 OUTLIER -68.18 113.86 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -102.93 -51.17 3.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.777 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 4.0 tt0 -104.75 149.88 25.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.448 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 17.7 p -138.02 149.43 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 111.654 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.94 24.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.381 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' CG ' HG13 ' A' ' 22' ' ' ILE . 2.5 mtmt -51.62 104.73 0.45 Allowed Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 91.6 Cg_endo -87.65 -44.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.662 2.242 . . . . 0.0 111.926 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.94 164.3 22.68 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.959 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.61 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.2 49.37 0.84 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.873 0.368 . . . . 0.0 110.91 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.1 t -89.36 137.89 20.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.635 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.46 145.56 43.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.101 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 11' ' ' LYS . 15.5 t -137.62 103.38 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.849 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 8' ' ' ALA . 10.7 tttt -70.65 135.09 48.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 9' ' ' ASP . 10.6 t -78.87 175.22 10.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.39 -54.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.823 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -72.76 -173.54 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.666 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -56.67 -16.59 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.059 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 p30 45.43 36.8 2.58 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.358 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -174.0 78.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.76 20.94 18.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.177 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 t 53.22 74.91 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.924 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.811 0.339 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.26 68.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.15 167.8 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 53' ' ' LEU . 16.2 pttt -157.02 138.42 13.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -88.26 134.84 33.69 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.24 1.019 . . . . 0.0 112.214 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 53.8 m -109.52 172.88 6.59 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.4 -1.727 . . . . 0.0 111.09 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -88.58 34.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.438 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 166.73 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -81.17 -59.62 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.95 -15.89 63.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.243 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.1 t 65.83 76.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.849 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.65 -51.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.051 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -65.19 141.37 98.21 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 45.0 Cg_exo -56.24 176.28 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.525 2.15 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.2 tp -105.46 -46.5 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.26 0.552 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 76.5 p 179.66 -169.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.311 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 7.8 ttp -120.08 137.52 54.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.809 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -145.94 136.55 24.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 27' ' ' ALA . 32.5 t -100.82 157.3 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.309 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -71.36 125.61 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 86' ' ' ARG . 13.6 mt -85.57 -4.93 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.8 OUTLIER 167.71 175.05 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.065 0.459 . . . . 0.0 110.882 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.33 142.54 45.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.686 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -161.08 89.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.105 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.437 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.1 ptt? -65.34 80.07 0.06 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.17 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.103 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.33 53.26 4.19 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.707 2.271 . . . . 0.0 112.399 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -132.94 90.41 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.28 29.81 19.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 59.92 41.25 18.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.824 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -168.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.446 HD21 ' CG2' ' A' ' 65' ' ' VAL . 8.8 tp -80.04 106.72 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -68.9 169.96 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.453 HG22 ' HB1' ' A' ' 27' ' ' ALA . 19.2 mm -117.44 142.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.678 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.1 143.7 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.098 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 2.0 mmm180 -45.09 157.78 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.973 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.0 39.16 4.98 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.451 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -119.44 109.74 16.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.726 0.298 . . . . 0.0 110.58 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 51.3 t -69.46 155.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.176 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.5 t -146.27 168.3 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 120.902 0.382 . . . . 0.0 111.592 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' H ' HG12 ' A' ' 47' ' ' VAL . 15.0 m-85 -136.5 97.14 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.656 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 62' ' ' GLY . 37.8 t -69.89 134.4 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.034 0.445 . . . . 0.0 111.092 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 3.9 m-85 -107.92 -24.98 11.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 p -153.45 166.56 32.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.084 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 10.5 tmtt? -138.03 83.16 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 11' ' ' LYS . 5.6 tt -63.7 132.77 52.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 1.9 pttp -139.29 -167.05 2.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.48 -60.83 2.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.84 -13.21 15.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.481 0.181 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.85 55.17 0.25 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.162 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 ttm180 -54.56 -28.17 43.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.35 -2.38 25.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.961 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.6 90.58 3.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.452 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 24.3 m0 -85.79 154.85 21.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.717 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -100.03 124.28 8.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.153 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.51 -167.54 16.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.976 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.39 127.12 6.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.785 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.97 145.58 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-O 121.932 0.872 . . . . 0.0 110.896 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -102.38 153.98 19.51 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.102 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.36 67.97 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.349 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.68 40.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 31.97 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -159.84 154.36 24.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.37 87.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.524 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -179.19 60.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.661 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.4 tt -68.52 106.58 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.93 79.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.97 130.18 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.65 118.23 33.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.701 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -65.12 156.44 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.75 -166.08 11.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -129.61 128.63 43.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.611 ' HZ ' HG11 ' A' ' 47' ' ' VAL . 23.3 p90 -159.1 157.32 27.75 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.663 ' O ' HG22 ' A' ' 84' ' ' ILE . 17.8 Cg_endo -59.69 163.54 13.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.584 2.189 . . . . 0.0 112.284 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 1.2 t -87.19 -36.61 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.58 -26.87 9.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.35 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG23 HG13 ' A' ' 85' ' ' VAL . 10.2 tp -75.61 -16.04 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.46 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.682 HG13 HG23 ' A' ' 84' ' ' ILE . 30.4 m -126.43 173.47 12.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.0 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HD2' HD21 ' A' ' 28' ' ' LEU . 19.5 ttt-85 -134.37 106.44 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.507 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.809 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 44.7 mt-10 -66.05 115.53 6.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.28 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.27 -51.23 3.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.494 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 37.7 tp60 -103.62 149.28 25.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.398 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 12.3 p -137.98 149.44 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 0.0 111.656 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -155.4 26.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.527 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HD3' ' CG ' ' A' ' 95' ' ' LYS . 27.7 ttmt -65.57 108.76 2.36 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.433 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.954 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 83.2 Cg_endo -92.96 -12.91 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.942 2.428 . . . . 0.0 112.684 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -148.99 170.35 29.36 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.817 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.561 ' O ' HD23 ' A' ' 12' ' ' LEU . 12.5 mtmt -152.16 52.89 0.8 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.261 0.553 . . . . 0.0 110.225 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.9 t -86.32 135.52 24.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.266 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.51 137.13 37.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.62 99.14 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.848 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -60.8 127.89 33.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -99.78 109.5 21.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -170.8 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -140.86 -70.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -53.84 -23.42 12.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.833 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.73 79.29 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.72 97.4 10.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -168.84 144.88 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.1 m -60.89 112.87 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.834 0.349 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.75 90.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.791 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.82 157.75 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.1 ttpt -152.29 134.02 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 139.58 30.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.131 0.967 . . . . 0.0 112.369 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.16 157.56 43.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.373 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.853 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.27 64.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.275 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 60.98 -174.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -68.39 72.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -170.17 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.8 m 57.59 30.39 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 t -94.92 -43.66 8.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.22 148.14 62.65 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.24 161.85 41.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.175 . . . . 0.0 112.453 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.2 tp -75.83 -47.12 33.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.513 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 64.6 p 178.27 -169.36 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.109 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 2.8 ttm -119.86 138.36 53.45 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.885 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.03 134.42 19.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 111.547 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 46' ' ' VAL . 22.6 t -101.46 151.17 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.5 130.56 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.079 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 17.2 tp -95.47 3.38 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.407 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 161.07 173.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.848 0.459 . . . . 0.0 111.137 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 21.5 t70 -66.71 141.3 57.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.968 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 76.8 t80 -161.01 83.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.445 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 1.0 OUTLIER -65.07 133.8 52.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.292 -179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.88 140.53 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.02 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 51.3 Cg_exo -53.95 -52.67 7.87 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.1 -165.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 178.14 42.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.848 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 27.7 m-85 -78.04 -178.29 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.52 133.67 48.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.445 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 3.0 t -83.89 155.34 22.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.547 HD11 ' CG ' ' A' ' 80' ' ' PHE . 5.3 mp -120.09 110.75 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.643 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 8.1 t-80 -104.73 154.69 19.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.452 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -45.99 158.94 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.69 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 46.91 49.3 17.69 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.285 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -134.13 107.25 7.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 26' ' ' VAL . 59.6 t -69.76 156.1 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.455 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.8 t -146.1 167.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 120.848 0.356 . . . . 0.0 111.465 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' H ' HG12 ' A' ' 47' ' ' VAL . 4.6 m-85 -135.03 96.43 3.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.768 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 62' ' ' GLY . 39.5 t -69.87 131.72 33.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.851 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.22 -24.92 8.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 m -147.35 154.81 41.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -138.22 81.93 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.815 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 124.47 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.688 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -125.95 -167.92 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.04 18.95 43.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.06 -31.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.85 28.86 3.17 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.921 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -50.91 -35.36 32.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.006 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -7.68 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.747 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -120.53 89.97 3.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -83.81 141.16 31.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -94.51 137.9 13.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.275 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -165.75 -156.89 9.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.729 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.35 122.68 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.817 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.14 148.1 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.949 0.881 . . . . 0.0 110.928 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.36 144.86 49.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.984 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . 150.86 70.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.432 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.66 125.91 28.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.978 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 67' ' ' GLY . 56.7 m-85 -124.19 175.96 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.8 99.27 3.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.09 70.35 1.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.54 60.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.643 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 2.0 mt -86.86 129.24 34.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.914 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.12 99.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.64 116.71 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.85 138.72 18.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 63' ' ' GLY . 6.7 tp -68.12 121.66 16.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.3 160.44 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' O ' ' CZ ' ' A' ' 60' ' ' PHE . 28.3 m-85 -122.12 119.39 31.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CG ' HD11 ' A' ' 41' ' ' ILE . 53.2 p90 -159.03 155.48 24.44 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.137 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.04 142.15 96.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.732 2.288 . . . . 0.0 112.316 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.45 -15.44 60.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.318 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.5 m -55.1 -22.94 18.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.721 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.05 24.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 111.68 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 27' ' ' ALA . 1.2 m -147.72 166.61 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -131.31 105.61 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.744 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.8 mt-10 -68.97 115.63 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.986 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.03 -50.5 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.757 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 4.7 tt0 -103.87 149.95 24.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.9 p -138.01 149.39 46.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.279 0.561 . . . . 0.0 111.648 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.79 24.49 0.67 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.462 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -51.17 104.83 0.46 Allowed Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.816 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.853 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -86.6 -43.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.6 2.2 . . . . 0.0 112.057 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.73 162.35 24.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.024 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.39 50.59 0.83 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.99 0.424 . . . . 0.0 110.737 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 7.7 t -91.3 139.97 16.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.5 152.63 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' LYS . 20.8 t -145.05 105.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.778 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -60.88 138.37 58.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 104' ' ' ASP . 37.6 m -80.02 166.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.63 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 100' ' ' THR . 1.9 m-20 -128.89 -62.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.685 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -172.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.577 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -61.04 -12.5 11.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.123 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.517 ' HB2' HG21 ' A' ' 100' ' ' THR . 31.4 t0 63.15 30.38 16.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.754 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -163.63 137.73 5.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -132.99 98.36 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -178.86 158.9 1.0 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.822 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.757 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' HD21 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -101.08 98.16 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 159.3 25.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' VAL . 3.8 ptpt -141.92 130.39 22.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.325 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' CA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.52 156.67 18.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 m -150.54 178.52 8.99 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.561 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.811 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -67.85 80.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.876 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 4.0 m-20 62.51 -176.09 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -68.67 71.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -170.1 -53.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.2 t 61.18 40.19 15.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.77 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -98.16 -44.46 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.85 136.19 51.3 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.55 174.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.421 2.08 . . . . 0.0 112.306 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -97.6 -47.87 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.568 ' CB ' HG22 ' A' ' 90' ' ' THR . 85.8 p -179.11 -169.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.348 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 8.7 ttp -124.59 135.28 52.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.77 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -144.07 136.57 26.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 0.0 111.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 46' ' ' VAL . 22.9 t -99.43 151.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.635 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.75 127.36 31.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -93.55 -0.58 56.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.35 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' A' ' 84' ' ' ILE . 9.9 pt20 169.4 175.42 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.014 0.435 . . . . 0.0 111.124 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 20.1 t70 -76.27 138.09 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.854 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HD2' HD13 ' A' ' 41' ' ' ILE . 46.6 t80 -161.17 85.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.441 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 ttm -64.89 135.53 55.82 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' CB ' ' A' ' 38' ' ' PHE . . . -38.71 138.67 0.77 Allowed Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.188 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.89 -49.75 6.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.493 2.128 . . . . 0.0 112.14 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -170.58 -176.11 2.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 22.1 t 59.3 25.46 14.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 53.38 47.71 23.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -70.29 -166.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.571 HD21 HG22 ' A' ' 65' ' ' VAL . 6.9 tt -101.21 125.77 47.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.251 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.451 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.7 t -84.96 159.0 20.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.25 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.699 HD13 ' HD2' ' A' ' 31' ' ' TYR . 4.0 mp -124.64 105.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.731 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 61.0 t60 -100.35 150.53 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.396 . . . . 0.0 111.484 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -44.97 160.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.755 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.97 49.04 6.31 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.459 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -134.19 111.14 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 110.918 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 26' ' ' VAL . 58.6 t -69.74 155.0 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.391 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 65' ' ' VAL . 4.0 t -150.05 148.76 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.382 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.6 m-85 -116.53 99.94 7.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 22' ' ' ILE . 41.0 t -69.82 131.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.937 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.89 -25.92 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.42 168.92 12.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.111 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -137.99 90.73 2.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD21 ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -58.5 144.52 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -133.88 -159.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.017 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.03 -59.65 3.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.888 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.43 -3.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.539 0.209 . . . . 0.0 111.108 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.18 70.51 0.13 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.566 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -53.98 -40.1 66.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 60' ' ' PHE . 4.0 pp -60.47 -26.67 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.735 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -64.65 74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.173 0.511 . . . . 0.0 110.608 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 59' ' ' LEU . 14.8 m0 -81.74 119.54 24.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.165 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.94 114.18 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.205 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.51 -152.61 5.72 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.763 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.65 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.12 129.77 7.55 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.46 146.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.724 0.773 . . . . 0.0 110.698 -179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.91 147.58 8.96 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -138.82 103.9 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.06 165.37 24.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -97.95 54.69 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.61 35.23 4.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.86 74.44 1.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 t0 179.61 60.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.088 0.471 . . . . 0.0 110.672 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 14.5 tp -87.16 104.56 16.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.895 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.97 66.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.24 139.17 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -141.79 136.89 31.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.08 146.65 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.91 20.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.644 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 17.5 m-85 -105.94 124.97 50.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.66 0.267 . . . . 0.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 41' ' ' ILE . 18.7 p90 -159.2 157.49 27.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.944 0.402 . . . . 0.0 111.688 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG2' HD13 ' A' ' 84' ' ' ILE . 10.2 Cg_endo -53.73 129.8 35.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.057 2.505 . . . . 0.0 112.338 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 73.1 p -70.93 -15.99 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.5 t -52.98 -28.19 22.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.488 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.681 ' O ' HG22 ' A' ' 84' ' ' ILE . 4.2 mp -91.07 16.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.805 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 27' ' ' ALA . 2.5 m -143.96 164.24 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.758 0.313 . . . . 0.0 110.945 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -131.17 108.99 10.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.583 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 4.6 mt-10 -74.18 119.23 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.44 -50.03 3.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.583 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 3.2 tt0 -101.07 151.24 22.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.39 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.2 149.76 46.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 111.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.2 tt -155.8 39.32 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.563 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -93.24 104.82 13.18 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.475 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.811 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -76.75 -34.98 2.16 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.452 2.101 . . . . 0.0 112.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -126.77 163.3 20.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.487 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 52.16 0.82 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.13 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 2.4 t -96.77 133.81 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.05 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HA ' ' CA ' ' A' ' 12' ' ' LEU . 27.8 t0 -71.76 119.26 15.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.149 0.499 . . . . 0.0 111.606 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 t -102.72 109.49 26.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.955 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 89.74 1.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 11' ' ' LYS . 11.6 t -79.01 164.59 24.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.79 158.26 5.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.08 -68.53 0.16 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.123 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -55.53 -20.97 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.3 -40.09 47.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.18 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 60.06 171.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.4 163.06 32.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.0 p -171.38 126.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.705 ' HB1' ' HE2' ' A' ' 99' ' ' LYS . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.852 0.358 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -112.21 120.97 43.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.38 154.52 43.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.19 150.96 41.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.21 135.18 33.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.222 1.01 . . . . 0.0 112.402 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t -104.85 155.29 19.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.424 -1.716 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -87.15 43.23 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.119 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 165.21 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.45 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -81.19 -56.35 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -92.2 13.32 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.414 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 m 57.54 81.18 0.15 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.78 0.324 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -145.18 38.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.95 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -167.85 144.37 3.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.961 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.38 149.52 56.85 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.564 2.176 . . . . 0.0 112.196 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 14' ' ' ALA . 1.5 tp -74.33 -49.21 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.667 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.5 p -174.25 -168.74 0.41 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.591 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.407 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 2.3 ttp -121.11 141.74 50.52 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.88 128.85 14.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.05 0.453 . . . . 0.0 111.634 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 21.2 t -96.94 149.88 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.81 127.09 29.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.21 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -91.71 9.02 34.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.041 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 1.5 mt-30 154.53 164.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.92 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.79 130.39 39.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.782 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CE1' ' CD1' ' A' ' 84' ' ' ILE . 9.9 t80 -161.22 104.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.108 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.476 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 8.1 ttt -65.3 136.4 56.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.215 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.78 148.25 0.26 Allowed Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.002 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.66 -51.51 10.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.554 2.169 . . . . 0.0 112.319 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -170.54 -173.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 m 60.79 20.25 10.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.255 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.86 51.96 14.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.686 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -76.73 -173.11 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 65' ' ' VAL . 8.6 tp -81.11 107.36 13.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.2 t -70.74 170.09 13.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.17 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.3 mp -122.87 139.85 48.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.538 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -135.23 140.66 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.133 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.0 mmm180 -42.66 160.98 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.948 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.26 42.66 3.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.316 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -130.46 112.4 13.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 47' ' ' VAL . 69.4 t -69.89 157.39 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.333 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.687 HG13 ' C ' ' A' ' 64' ' ' SER . 13.6 t -148.67 131.09 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.815 0.341 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -98.22 101.07 12.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.105 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 62' ' ' GLY . 28.9 t -73.59 132.04 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -113.29 -24.06 9.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.306 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.78 150.51 40.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 81.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' A' ' 57' ' ' GLY . 6.4 tt -66.05 116.74 7.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.4 pttt -125.0 -164.8 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -63.37 1.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.075 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -123.75 14.82 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.553 0.216 . . . . 0.0 111.033 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' A' ' 53' ' ' LEU . . . -167.89 29.67 0.17 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.99 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.87 -28.53 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.147 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -4.52 35.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.838 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.5 92.45 3.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.196 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -94.08 152.22 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -102.73 128.84 9.68 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.412 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.81 -159.88 9.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.795 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.687 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.2 128.78 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.632 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.3 152.96 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 121.867 0.842 . . . . 0.0 110.699 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -57.29 160.82 3.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.996 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.94 45.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -144.1 117.32 8.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -3.83 47.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -145.84 118.24 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.708 0.29 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.1 -133.49 12.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.556 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 178.99 60.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.053 0.454 . . . . 0.0 110.716 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -163.42 82.58 0.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.863 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.21 77.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.2 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' HD22 ' A' ' 39' ' ' LEU . 65.0 mtm-85 -85.39 102.85 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 120.19 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.47 -175.23 20.59 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.544 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.77 117.33 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.787 0.327 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.99 155.63 24.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.51 132.6 46.9 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.542 2.161 . . . . 0.0 112.184 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.97 -24.83 64.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.8 m -48.18 -31.87 6.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.61 HG22 HG21 ' A' ' 41' ' ' ILE . 14.1 mt -67.25 -38.94 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.145 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.6 m -102.43 -179.24 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.146 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.25 105.04 5.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.343 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.904 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -67.4 129.16 39.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.319 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.28 -48.61 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.7 tp60 -101.79 152.58 20.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.294 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.667 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.7 p -137.97 149.86 46.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.157 0.503 . . . . 0.0 111.755 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.6 tt -154.28 40.53 0.47 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.723 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 106.95 20.29 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.269 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.816 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 89.1 Cg_endo -83.07 -28.16 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.525 2.15 . . . . 0.0 112.004 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.29 172.19 18.71 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.36 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.714 ' O ' HD23 ' A' ' 12' ' ' LEU . 54.2 pttt -151.87 50.15 0.8 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.938 0.399 . . . . 0.0 110.452 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -83.65 139.12 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.86 136.12 37.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -128.6 103.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.026 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.705 ' HE2' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -69.0 110.12 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 163.64 25.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -142.1 -81.32 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.21 -24.31 5.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.418 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -49.16 -26.26 2.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 111.948 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.33 69.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -172.49 111.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.51 98.38 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -177.07 103.64 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.935 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 53' ' ' LEU . 20.3 t0 -85.79 120.26 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.51 157.64 31.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB3' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -152.77 146.72 25.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.25 140.17 29.75 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.164 0.983 . . . . 0.0 112.505 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.85 178.93 5.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.563 -1.653 . . . . 0.0 111.218 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.886 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -86.12 47.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.381 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD1' HG21 ' A' ' 96' ' ' VAL . 6.2 t0 52.14 179.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 63.12 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -170.07 34.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.65 37.16 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.8 t -81.34 -42.59 20.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -91.67 137.91 25.4 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.87 -176.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.493 2.129 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.86 -46.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.536 . . . . 0.0 111.067 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -177.79 -168.78 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.38 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 24.2 ttp -121.28 142.72 49.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . . . -147.96 125.36 11.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 46' ' ' VAL . 23.5 t -97.44 150.67 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.323 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -67.17 121.14 14.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.766 HD13 ' HG3' ' A' ' 86' ' ' ARG . 20.8 tp -85.36 1.09 50.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.103 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER 167.62 174.25 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 121.044 0.45 . . . . 0.0 110.817 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.87 148.76 45.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.739 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' HD2' HD12 ' A' ' 41' ' ' ILE . 44.7 t80 -161.01 83.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.0 mtt -65.62 80.42 0.07 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.086 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.7 98.98 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.063 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.18 55.46 5.41 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.77 85.44 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.0 m 60.31 34.62 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 59.87 56.99 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.49 -168.14 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 tp -81.43 102.56 10.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 32' ' ' MET . 1.0 OUTLIER -67.6 157.65 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.71 ' CD1' HG21 ' A' ' 84' ' ' ILE . 22.0 mt -113.42 143.25 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.657 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.397 . . . . 0.0 111.247 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -45.34 161.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.808 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.06 42.84 6.82 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.461 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HG2' HG12 ' A' ' 65' ' ' VAL . 9.8 tt0 -126.71 108.06 10.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 26' ' ' VAL . 60.1 t -70.85 154.77 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.6 t -149.46 153.05 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 95.8 m-85 -120.99 107.62 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 22' ' ' ILE . 31.0 t -69.87 131.48 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.063 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.37 8.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.2 p -153.71 148.78 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 1.3 mtmp? -138.27 81.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' OD1' ' A' ' 9' ' ' ASP . 5.0 tt -73.23 136.85 44.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.711 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -130.2 -169.86 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.94 11.87 58.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.39 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.61 -32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.698 0.285 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.61 5.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.792 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -49.16 -43.48 41.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 111.085 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -13.49 59.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.578 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -117.76 87.59 2.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.86 0.362 . . . . 0.0 111.148 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.462 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 14.7 m0 -84.97 142.08 29.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.682 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.25 126.13 8.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.547 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.84 -159.08 9.24 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.647 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.54 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.39 132.04 8.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.6 150.58 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.886 0.85 . . . . 0.0 110.628 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.6 pt20 -57.13 163.58 2.05 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.113 -1.403 . . . . 0.0 111.056 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -137.79 69.14 0.5 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.21 37.21 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.73 97.83 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.17 117.09 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.91 71.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.435 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 78.73 55.5 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.341 0.591 . . . . 0.0 110.359 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -60.05 153.82 20.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.922 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.72 73.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 151.92 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -147.68 129.53 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.22 141.74 52.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.43 173.46 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 41.8 m-85 -118.75 122.86 43.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.983 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CD1' HD11 ' A' ' 41' ' ' ILE . 19.3 p90 -159.06 154.94 23.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 84' ' ' ILE . 31.2 Cg_endo -63.75 121.1 8.71 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.569 2.179 . . . . 0.0 112.168 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.462 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 13.1 p -64.46 -25.47 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 t -48.1 -27.73 2.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.5 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.7 tp -77.71 -31.53 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.343 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 27' ' ' ALA . 29.4 m -104.62 147.58 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.198 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.766 ' HG3' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -106.51 125.37 50.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 2.1 mt-10 -76.33 115.34 15.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.026 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.34 -50.65 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.78 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -104.59 149.08 25.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.618 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 11.1 p -138.02 149.47 46.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.199 0.523 . . . . 0.0 111.579 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 27.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.538 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mttt -50.77 104.92 0.46 Allowed Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.666 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.886 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.7 Cg_endo -86.57 -23.61 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.742 2.295 . . . . 0.0 112.251 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 164.85 31.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.336 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.8 ptmm? -151.41 50.19 0.82 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.967 0.413 . . . . 0.0 110.512 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 15' ' ' ASP . 3.9 t -89.08 139.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.035 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.6 150.87 44.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.781 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.2 t -145.11 106.73 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.99 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.7 112.63 8.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.961 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 9' ' ' ASP . 11.5 t -78.88 163.89 24.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.029 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 177.9 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -76.77 -26.04 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -52.75 -23.06 6.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.958 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -45.83 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 59.34 -169.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.933 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -150.93 117.08 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t 60.09 108.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.774 0.321 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.91 122.43 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.53 172.23 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ptmt -157.03 153.91 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.13 141.0 28.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.144 0.973 . . . . 0.0 112.413 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t -131.75 165.17 24.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.236 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.22 60.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.28 -167.1 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -18.68 59.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.366 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.75 -66.48 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m 60.24 31.65 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.99 32.67 5.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -154.63 131.08 5.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.49 144.78 49.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.387 2.058 . . . . 0.0 112.304 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.7 tp -62.07 -48.25 89.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.038 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 90' ' ' THR . 87.7 p -178.14 -168.26 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.391 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.44 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -119.94 140.58 50.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.818 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -148.13 133.16 18.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.039 0.447 . . . . 0.0 111.649 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 27' ' ' ALA . 26.1 t -87.21 160.0 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.795 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -76.85 132.54 39.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.227 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.4 tt -93.82 7.35 45.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.248 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.758 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.7 OUTLIER 167.19 163.87 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 111.86 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 58.3 t0 -99.21 123.26 43.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' HD12 ' A' ' 41' ' ' ILE . 22.8 p90 -161.57 127.58 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.9 131.05 45.33 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.12 100.46 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.978 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.73 58.97 6.64 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.556 2.171 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -171.47 97.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m 62.22 -80.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 3.0 m-85 -60.03 -175.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.91 128.25 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.164 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -81.01 170.07 16.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.561 HD12 ' CE1' ' A' ' 31' ' ' TYR . 42.3 mt -127.43 153.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 29.2 t-80 -142.13 136.32 29.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.5 mmm180 -42.95 159.0 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.277 0.561 . . . . 0.0 111.967 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.25 29.66 1.06 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.342 -0.844 . . . . 0.0 113.573 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -114.35 120.1 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.8 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 47.2 t -70.06 155.05 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.708 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.904 HG22 HG12 ' A' ' 65' ' ' VAL . 3.1 t -146.48 150.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -116.59 99.33 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.976 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 62' ' ' GLY . 34.2 t -69.87 129.47 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.2 -24.04 15.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.4 t -164.64 168.23 18.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 2.4 mtmt -134.38 81.97 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 tt -68.56 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 58' ' ' ARG . 34.7 mttm -118.71 26.72 9.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.014 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.75 71.47 0.38 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.999 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 66.46 29.97 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.465 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.31 53.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -49.75 -23.26 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 111.573 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -2.15 9.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.71 89.72 3.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.924 0.392 . . . . 0.0 111.068 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 16.4 m0 -94.11 150.01 20.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.812 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -92.13 124.35 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.81 -171.62 25.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.84 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.575 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.44 133.38 9.41 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.904 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.37 142.09 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 121.744 0.783 . . . . 0.0 111.16 -179.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -58.43 140.71 53.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.124 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -126.52 -79.87 0.33 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.9 132.55 2.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.782 0.325 . . . . 0.0 110.831 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.77 53.02 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.81 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 82.56 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.55 50.18 67.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.643 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 179.64 60.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.073 0.463 . . . . 0.0 110.766 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -105.58 104.1 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.892 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.12 77.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.84 165.78 11.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.62 107.84 19.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD23 ' OG ' ' A' ' 64' ' ' SER . 21.5 mt -59.63 134.14 56.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.36 -175.84 14.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.8 134.5 53.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -159.13 152.59 18.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 84' ' ' ILE . 35.9 Cg_endo -65.03 144.11 81.08 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.153 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.7 t -76.67 -24.84 53.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.01 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -60.46 -22.46 63.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.548 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 29' ' ' GLN . 7.7 tp -98.02 25.81 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.799 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.79 -177.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 26' ' ' VAL . 7.3 ttp180 -143.18 108.84 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.565 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 46.0 mt-10 -75.18 121.07 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.008 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.38 -49.75 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.748 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 13.9 tt0 -105.1 153.47 21.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.678 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 23' ' ' SER . 1.8 p -138.14 149.75 46.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.276 0.56 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -156.93 41.98 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.05 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -92.78 104.87 12.64 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.524 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 74.3 Cg_endo -74.4 -26.14 12.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.356 2.037 . . . . 0.0 112.005 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -142.75 165.26 26.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.354 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.21 49.55 0.84 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.997 0.427 . . . . 0.0 110.567 179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 t -90.99 141.0 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.862 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.43 151.42 41.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.6 t -144.99 104.5 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.959 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 92.76 0.76 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.7 t -78.82 168.8 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.73 163.5 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.4 -60.23 2.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -55.02 -21.89 13.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.891 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -72.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.91 108.23 18.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -156.7 145.74 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.52 132.58 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.895 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -90.08 112.26 23.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.06 151.18 32.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' VAL . 7.6 pttt -149.1 145.78 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.4 mp -88.24 143.25 27.15 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.16 0.981 . . . . 0.0 112.534 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.8 t -132.89 164.38 27.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.518 -1.674 . . . . 0.0 111.262 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.866 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -73.5 60.53 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER 62.55 -172.27 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -56.41 -22.68 33.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.237 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.81 -62.36 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 82.5 m 59.15 26.87 15.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -80.12 -78.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.958 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' A' ' 91' ' ' LEU . 2.2 m-70 -63.6 132.6 95.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.695 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 50' ' ' PHE . 52.3 Cg_exo -52.8 -177.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.401 2.067 . . . . 0.0 112.238 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -79.55 -47.27 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.252 0.548 . . . . 0.0 110.708 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.677 ' OG ' HG22 ' A' ' 90' ' ' THR . 13.2 m -174.04 -169.05 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.519 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 33.6 ttm -130.91 119.38 22.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.56 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -125.75 138.63 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 111.511 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 46' ' ' VAL . 21.5 t -100.13 149.51 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.415 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.13 129.96 44.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.239 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' CB ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -95.18 7.39 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.3 mt-30 155.77 161.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.199 0.6 . . . . 0.0 110.943 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -64.46 141.32 58.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.757 ' HD2' HD13 ' A' ' 41' ' ' ILE . 7.2 t80 -161.17 86.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.466 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 6.3 ptm -65.22 96.93 0.24 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.245 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.89 99.78 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.014 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.49 17.72 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.73 2.287 . . . . 0.0 112.917 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.12 91.86 4.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.791 0.329 . . . . 0.0 110.938 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.1 t 67.28 -71.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.63 40.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.861 0.363 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -68.33 -175.01 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 65' ' ' VAL . 12.4 tp -80.65 117.17 21.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.5 t -74.46 170.26 16.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 80' ' ' PHE . 3.5 mp -123.71 139.32 50.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.541 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.1 140.91 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.88 0.371 . . . . 0.0 111.286 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -43.84 157.24 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.821 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.84 44.33 7.07 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.37 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -134.2 111.26 10.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 HG22 ' A' ' 26' ' ' VAL . 90.3 t -69.9 159.89 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.4 t -148.13 157.61 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.798 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 66' ' ' GLN . 9.0 m-85 -126.97 107.21 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG21 ' HE3' ' A' ' 61' ' ' TRP . 38.3 t -79.87 112.95 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 21' ' ' PRO . 1.5 m-85 -86.44 -34.68 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -142.83 156.22 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.851 0.358 . . . . 0.0 111.106 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 81.94 1.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.28 137.13 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' HD11 ' A' ' 12' ' ' LEU . 14.6 ptmt -131.24 -162.98 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.935 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.46 -59.35 4.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.981 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -5.49 12.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.97 65.59 0.17 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.7 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 13.3 ttp180 -52.08 -49.25 63.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.742 0.306 . . . . 0.0 111.492 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD13 ' HG3' ' A' ' 81' ' ' PRO . 1.7 pp -58.67 -25.66 63.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.746 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 74.53 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.199 0.523 . . . . 0.0 110.855 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.613 ' HE3' HG21 ' A' ' 49' ' ' VAL . 8.9 m0 -85.27 120.96 27.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 79' ' ' TYR . . . -87.79 115.47 4.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.466 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.96 -158.42 8.4 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.538 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 29.5 t -157.58 151.14 23.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.851 0.358 . . . . 0.0 110.299 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.714 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.73 146.81 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-O 121.761 0.791 . . . . 0.0 110.949 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.1 pt20 -52.68 160.33 0.91 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.035 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -89.27 -174.19 46.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.507 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.77 -65.66 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.91 -174.33 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 60.77 80.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.47 111.99 3.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.389 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -178.37 60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.045 0.45 . . . . 0.0 110.733 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.9 tt 56.68 111.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.372 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 178.19 73.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.056 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -165.84 109.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 116.04 31.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.39 118.03 20.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.06 163.18 13.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.665 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 62' ' ' GLY . 5.0 m-85 -114.82 123.59 49.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.684 0.278 . . . . 0.0 110.755 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 41' ' ' ILE . 6.4 p90 -159.24 163.79 22.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HG3' HD13 ' A' ' 59' ' ' LEU . 76.6 Cg_exo -49.67 134.51 33.84 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.814 2.343 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -82.58 -22.66 34.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -48.37 -31.0 5.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.364 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.617 HG23 HG13 ' A' ' 85' ' ' VAL . 7.6 tp -69.55 -28.22 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.254 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 84' ' ' ILE . 27.7 m -105.13 -177.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.079 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.97 119.19 10.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.67 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 10.3 mt-10 -80.77 130.15 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.18 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.01 -47.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 12.9 tp60 -104.84 94.35 5.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.677 HG22 ' OG ' ' A' ' 23' ' ' SER . 16.0 p -89.12 149.5 23.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 111.608 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -149.67 23.59 0.89 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.584 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -60.61 107.84 1.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.544 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.866 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 Cg_endo -85.79 -36.64 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.547 2.165 . . . . 0.0 112.101 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.52 165.5 24.45 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.116 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.2 ptmt -151.29 49.75 0.83 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.9 t -89.72 138.44 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.27 149.92 44.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.347 0.594 . . . . 0.0 111.276 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 11' ' ' LYS . 7.9 t -145.05 107.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.696 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 143.26 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.127 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 103' ' ' TRP . 90.0 m -84.01 151.25 25.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -137.53 70.56 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 66.47 13.3 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.551 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.468 ' HB2' HG23 ' A' ' 100' ' ' THR . 20.9 m95 -60.52 -19.83 58.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.79 0.329 . . . . 0.0 111.747 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -168.97 92.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.29 -57.92 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -111.91 156.43 22.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 148.77 40.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.842 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 10' ' ' ARG . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.24 109.82 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HD2' ' HB3' ' A' ' 8' ' ' ALA . 1.7 mpp_? -139.35 150.03 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' VAL . 5.7 ptmt -147.94 136.02 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.356 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -88.57 158.52 18.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.482 0.658 . . . . 0.0 110.727 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.1 m -150.54 173.51 14.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.543 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HA ' ' CA ' ' A' ' 94' ' ' GLY . . . -67.56 83.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.997 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.2 m-20 64.75 -179.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -69.25 70.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -170.14 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.0 t 59.97 34.55 21.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -94.39 -50.82 5.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.44 150.64 92.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 67.5 Cg_endo -74.01 145.06 35.04 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.515 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.4 tp -74.02 -45.13 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.179 0.514 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.4 p 178.86 -169.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.393 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.436 ' CE ' HG11 ' A' ' 46' ' ' VAL . 2.1 ttt -123.9 135.25 53.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.82 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.64 133.81 19.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.67 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 46' ' ' VAL . 22.2 t -99.38 151.2 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.902 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.92 126.49 27.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.193 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 86' ' ' ARG . 2.3 tp -90.39 0.39 57.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.178 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 167.0 174.78 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.74 145.19 52.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.7 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 81' ' ' PRO . 60.0 t80 -161.16 91.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.264 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.438 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.2 140.1 58.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.87 141.12 0.62 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.153 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 37.4 Cg_exo -56.87 -51.31 9.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.568 2.179 . . . . 0.0 112.259 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -171.81 -173.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.8 m 62.73 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -169.51 35.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.796 0.332 . . . . 0.0 110.915 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.649 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 44.9 m-85 -65.14 179.18 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD23 ' CG2' ' A' ' 65' ' ' VAL . 3.8 tp -98.14 127.85 44.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.6 t -79.76 170.03 17.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.451 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 80' ' ' PHE . 60.4 mt -127.67 138.24 55.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -127.19 151.38 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.6 mmm180 -45.29 162.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.824 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.6 44.57 5.36 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.384 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.07 109.84 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 26' ' ' VAL . 61.7 t -69.75 154.63 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.787 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG22 ' CG1' ' A' ' 65' ' ' VAL . 3.6 t -148.55 147.82 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 3.9 m-85 -115.73 98.07 6.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.5 t -69.96 131.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.8 m-85 -114.92 -26.11 7.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.335 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -135.83 155.0 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.418 . . . . 0.0 111.286 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 61' ' ' TRP . 15.6 mtpt -137.22 81.9 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.712 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.17 141.9 57.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.65 -157.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.94 77.53 0.34 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.78 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 64.87 16.48 10.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.95 1.03 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.869 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -52.03 -24.08 6.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 111.277 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -2.05 13.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.012 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.68 89.58 3.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 52' ' ' LYS . 10.3 m0 -92.77 141.79 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.681 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -87.71 135.16 12.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.214 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.81 -160.24 13.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.794 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.609 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.42 128.79 6.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' CG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.63 149.8 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-O 121.749 0.785 . . . . 0.0 110.615 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -58.34 159.56 6.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.275 -1.329 . . . . 0.0 110.986 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.23 -152.76 7.07 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.517 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.48 -47.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -174.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 89.75 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.76 73.16 0.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.82 60.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.063 0.459 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.15 106.15 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.948 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.39 73.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.96 170.26 9.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -110.64 105.93 15.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -59.82 119.31 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.96 -161.73 17.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -146.91 116.15 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.811 0.339 . . . . 0.0 110.827 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 41' ' ' ILE . 1.4 p90 -155.92 161.86 28.6 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 31' ' ' TYR . 76.4 Cg_exo -49.85 156.85 2.99 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 t -96.9 -38.18 9.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -48.84 -30.22 5.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.746 HG23 HG13 ' A' ' 85' ' ' VAL . 7.4 tp -65.85 -30.63 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 27' ' ' ALA . 33.7 m -113.52 144.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HB2' HD13 ' A' ' 28' ' ' LEU . 24.3 ttp180 -98.46 123.51 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.703 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.9 pt-20 -85.9 122.13 29.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.035 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -48.86 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -102.57 149.17 24.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.461 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 23' ' ' SER . 11.4 p -138.04 149.56 46.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.253 0.549 . . . . 0.0 111.63 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.76 26.97 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.542 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -63.15 107.28 1.16 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.294 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 14' ' ' ALA . 2.8 Cg_endo -79.53 -53.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.318 . . . . 0.0 111.633 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -118.63 168.35 13.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.188 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 52.18 0.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.963 0.411 . . . . 0.0 110.227 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 1.4 t -95.12 128.11 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.7 t70 -67.97 119.66 12.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.471 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.9 t -104.38 107.76 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.073 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -68.02 134.93 51.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 101' ' ' ASP . 99.1 m -110.17 162.27 14.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 100' ' ' THR . 0.4 OUTLIER -110.58 176.59 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -96.83 -33.57 11.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -55.01 -22.01 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.861 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.72 -69.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.46 142.91 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -142.96 128.95 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.96 154.48 18.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.809 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HA ' HD21 ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -171.97 -43.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -155.87 156.38 34.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -150.28 162.48 40.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD13 ' HE3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -88.06 142.09 28.05 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.007 0.908 . . . . 0.0 112.523 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.5 m -126.03 139.39 53.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -66.83 71.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.318 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.16 174.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.232 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 57.17 -88.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.27 51.72 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m 65.15 37.12 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.9 p -78.54 -32.55 47.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -112.9 157.56 40.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.15 -171.22 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.568 2.179 . . . . 0.0 112.231 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.6 tp -113.0 -46.3 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.325 0.583 . . . . 0.0 111.115 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.645 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.8 p -176.08 -167.75 0.24 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.602 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 2.1 ttp -127.75 130.33 48.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -136.21 155.53 49.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.515 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 86' ' ' ARG . 38.4 t -109.33 152.39 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.212 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -69.52 128.84 37.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 13.9 tp -89.61 0.43 56.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.3 OUTLIER 163.52 174.25 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 43.8 t0 -71.39 140.83 50.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HD2' HD12 ' A' ' 41' ' ' ILE . 40.0 t80 -160.77 83.58 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.065 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.479 ' HA ' ' CB ' ' A' ' 40' ' ' THR . 2.4 ptp -65.38 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.462 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.5 138.03 1.27 Allowed Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.085 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 38' ' ' PHE . 41.7 Cg_endo -67.4 -40.81 10.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.18 . . . . 0.0 112.554 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.56 175.48 12.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.901 0.381 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 37' ' ' ARG . 11.4 t -38.71 147.9 0.05 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.163 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 36' ' ' CYS . 11.5 ttp85 83.72 -28.06 0.1 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.971 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 62.2 m-85 -82.91 167.84 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 40' ' ' THR . 2.0 tt -130.53 150.59 51.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.429 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.605 ' O ' HD23 ' A' ' 39' ' ' LEU . 7.2 t -88.14 159.57 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.074 0.464 . . . . 0.0 111.421 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.707 HD11 ' CG ' ' A' ' 80' ' ' PHE . 16.0 mt -132.85 103.99 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.453 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 1.9 t60 -96.85 150.96 20.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.576 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.2 mmm180 -44.71 162.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.084 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 40.43 34.87 0.72 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.165 -0.925 . . . . 0.0 114.041 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -120.26 114.97 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.939 0.37 . . . . 0.0 110.463 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.7 t -69.84 151.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.992 0.425 . . . . 0.0 110.856 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.5 147.28 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.42 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 0.2 OUTLIER -116.95 98.23 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.813 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 61' ' ' TRP . 23.6 t -69.93 126.18 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.079 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.93 -28.45 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.974 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -148.51 158.0 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.941 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HD13 ' A' ' 12' ' ' LEU . 41.5 pttt -131.34 86.54 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 8' ' ' ALA . 2.5 tt -62.84 110.63 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD3' HD11 ' A' ' 12' ' ' LEU . 20.0 pttt -123.75 -161.46 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.867 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.29 -59.1 4.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.083 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.52 13.17 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 42.08 0.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.723 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -50.41 -26.97 5.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 111.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.57 1.93 15.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.979 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.75 89.93 3.21 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.602 ' CE3' HG11 ' A' ' 49' ' ' VAL . 6.1 m0 -96.84 139.47 32.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -98.62 141.65 15.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . 179.19 -156.05 17.51 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.92 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 t -157.3 157.94 35.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG13 HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.5 154.1 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.32 144.97 18.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.277 -1.328 . . . . 0.0 111.07 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -132.83 107.11 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.399 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -84.13 179.42 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.78 30.73 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -128.46 59.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.83 80.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -177.86 59.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.712 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.49 179.26 5.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.03 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.17 120.67 40.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -99.09 101.77 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 124.21 22.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.0 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -124.56 -153.48 8.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.35 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -146.09 129.22 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.912 0.386 . . . . 0.0 111.065 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.707 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.4 p90 -159.05 156.81 27.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.902 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.625 ' O ' HG22 ' A' ' 84' ' ' ILE . 28.5 Cg_endo -62.88 153.06 75.54 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.505 2.137 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 p -79.73 -25.31 41.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.127 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 p -51.46 -28.18 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.475 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.0 tp -82.83 1.09 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.654 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 27' ' ' ALA . 14.9 m -137.96 -178.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -144.05 109.3 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -75.56 128.22 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.279 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.5 -49.15 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.454 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 5.3 tt0 -100.99 152.0 21.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.367 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.645 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.1 p -138.27 149.86 46.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.21 0.528 . . . . 0.0 111.823 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.8 tt -153.91 39.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.52 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -90.86 105.2 11.3 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.227 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 74.5 Cg_endo -74.09 -26.03 13.27 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.394 2.063 . . . . 0.0 111.905 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -137.59 168.98 24.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -151.17 48.95 0.84 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.964 0.411 . . . . 0.0 110.501 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.32 139.83 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.93 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.99 144.13 41.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 11' ' ' LYS . 2.6 t -145.06 120.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.3 mtmp? -60.87 150.01 34.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.946 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -78.86 173.13 12.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.993 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -71.73 -174.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -74.29 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -53.8 -23.52 12.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.863 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.71 35.28 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.974 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 59.32 170.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.38 119.87 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 87.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -147.06 82.14 1.55 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.31 144.8 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.735 ' HE3' HD12 ' A' ' 53' ' ' LEU . 17.6 ttmt -143.87 144.75 31.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.3 mp -88.22 141.03 28.89 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.11 0.957 . . . . 0.0 112.497 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t -127.61 158.86 36.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.317 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.783 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.18 61.61 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 64.86 -177.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.933 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -54.87 -23.88 20.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -69.85 -55.96 8.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.059 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 84.4 m 56.77 25.84 10.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.32 -77.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 26.0 m-70 -58.99 151.78 53.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.14 177.65 7.95 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.501 2.134 . . . . 0.0 112.697 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -79.75 -44.44 23.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 69.4 p -179.41 -168.15 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.199 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.452 ' CB ' ' HB3' ' A' ' 89' ' ' GLN . 3.9 ttp -119.53 137.55 53.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.119 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.0 133.01 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.458 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 46' ' ' VAL . 23.8 t -99.56 151.95 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.396 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.875 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.66 123.3 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.159 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -86.36 -1.39 57.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.088 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.568 ' HG3' HD11 ' A' ' 84' ' ' ILE . 11.5 pt20 167.56 174.8 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.011 0.434 . . . . 0.0 110.992 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.04 145.98 53.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' HD12 ' A' ' 41' ' ' ILE . 60.8 t80 -161.08 85.09 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 50.3 mmm -65.58 88.39 0.09 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.73 95.91 0.1 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.2 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.36 92.78 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.703 2.269 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.13 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.97 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.2 m 62.15 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.029 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.12 73.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.654 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.28 -167.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 65' ' ' VAL . 11.1 tp -92.73 97.53 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -64.31 157.97 24.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.987 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 84' ' ' ILE . 10.9 mt -111.42 138.17 40.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -128.52 151.33 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 5.9 mmm180 -45.28 159.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.35 50.18 8.07 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.358 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.06 109.99 9.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.71 0.291 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 26' ' ' VAL . 63.3 t -69.82 155.5 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.1 t -150.22 157.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TYR . 3.0 m-85 -128.17 100.06 5.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.48 HG11 ' CE3' ' A' ' 61' ' ' TRP . 24.6 t -70.16 129.7 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 77' ' ' LEU . 20.3 m-85 -99.42 -26.6 14.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -163.98 167.02 20.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.095 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 6.4 pttt -138.05 116.85 12.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.735 HD12 ' HE3' ' A' ' 11' ' ' LYS . 7.6 tt -89.57 105.54 17.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -95.79 -159.42 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.07 74.85 0.67 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.929 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.49 16.1 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.9 15.33 0.9 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.95 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -25.41 63.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 111.029 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 pp -62.32 -15.06 45.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.778 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.74 89.81 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.48 ' CE3' HG11 ' A' ' 49' ' ' VAL . 8.0 m0 -82.85 -177.32 6.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.714 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.77 121.03 2.66 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.326 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 49' ' ' VAL . . . -156.36 -154.15 6.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.969 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.452 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.28 135.1 10.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.676 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -76.3 149.13 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.928 0.871 . . . . 0.0 111.068 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 2.0 pt20 -55.81 141.47 38.58 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.013 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -143.97 78.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.51 -42.33 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.05 148.54 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 60.29 176.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.2 128.93 14.37 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 t0 179.83 60.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 110.776 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.53 141.89 37.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.07 80.72 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.087 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.76 162.67 18.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -119.73 123.08 42.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -69.06 126.73 30.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.59 175.71 16.25 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.362 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 95.1 m-85 -115.73 128.62 56.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 0.0 110.708 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' A' ' 41' ' ' ILE . 12.1 p90 -159.08 157.3 27.78 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.469 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.898 ' O ' HG22 ' A' ' 84' ' ' ILE . 37.4 Cg_endo -65.97 136.13 43.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.032 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 18.3 p -71.27 -31.1 67.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.139 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -53.61 -30.13 41.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.675 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 81' ' ' PRO . 6.7 tp -71.85 -29.54 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.544 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 27' ' ' ALA . 28.6 m -108.82 156.47 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.336 . . . . 0.0 111.024 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.758 ' HB2' HD23 ' A' ' 28' ' ' LEU . 11.3 ttm180 -112.59 112.42 23.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.63 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 16.9 pt-20 -70.77 123.47 22.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.053 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -110.99 -49.49 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.656 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.452 ' HB3' ' CB ' ' A' ' 24' ' ' MET . 1.0 OUTLIER -102.99 150.5 23.48 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.397 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 16.4 p -138.08 149.4 45.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.36 0.6 . . . . 0.0 111.751 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.94 27.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.09 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 22' ' ' ILE . 2.1 mtmt -50.26 104.65 0.44 Allowed Pre-proline 0 CA--C 1.529 0.162 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.007 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.783 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 96.4 Cg_endo -89.23 -48.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.839 2.36 . . . . 0.0 112.039 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -132.73 163.34 24.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.674 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.9 pttp -151.16 49.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.834 0.35 . . . . 0.0 111.017 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 6.6 t -87.15 138.88 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.337 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.99 149.39 43.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.306 0.574 . . . . 0.0 111.262 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' LYS . 6.2 t -145.11 109.44 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 136.46 58.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 103' ' ' TRP . 84.8 m -91.28 143.16 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -157.21 33.83 0.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -176.55 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.647 ' HB2' HG23 ' A' ' 100' ' ' THR . 16.0 m95 -51.6 -25.25 6.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.826 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -96.48 46.86 1.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.808 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.36 156.75 36.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.72 146.35 51.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.7 t -61.14 94.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.934 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -136.28 106.09 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.987 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.11 163.21 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.8 140.46 23.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.12 139.95 29.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.243 1.02 . . . . 0.0 112.446 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 158.93 43.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.411 -1.722 . . . . 0.0 110.681 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.98 72.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.65 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.54 -177.31 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.95 -30.86 62.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.64 -60.16 2.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 23.9 t 58.67 31.06 20.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 p -67.38 -50.96 57.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.31 152.53 73.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.77 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.25 175.26 6.96 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.578 2.185 . . . . 0.0 112.441 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.1 tp -83.5 -47.69 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.315 0.579 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.726 ' CB ' HG22 ' A' ' 90' ' ' THR . 84.1 p -174.7 -168.13 0.34 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.836 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.458 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 20.1 ttp -125.35 138.08 54.05 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -148.05 132.0 17.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.063 0.459 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 27' ' ' ALA . 11.0 p -89.25 164.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -81.27 121.03 25.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.917 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 86' ' ' ARG . 3.0 tp -81.69 -4.3 55.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.386 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 166.6 174.65 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.091 0.472 . . . . 0.0 110.84 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.73 142.39 48.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB3' HG21 ' A' ' 84' ' ' ILE . 40.3 t80 -161.05 93.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.949 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.448 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.1 tpp -65.34 103.02 0.74 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.245 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.87 99.52 0.19 Allowed Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.05 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.71 56.08 5.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.626 2.218 . . . . 0.0 112.359 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -149.04 89.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 64.25 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -172.39 48.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.16 -174.52 2.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 115.27 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.001 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.4 t -74.13 169.95 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.706 HD11 ' CE2' ' A' ' 80' ' ' PHE . 27.5 mm -116.05 142.11 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.647 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -134.93 144.66 47.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 3.4 mmm180 -44.57 157.7 0.06 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.188 0.518 . . . . 0.0 111.886 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 44.05 35.93 3.7 Favored Glycine 0 C--N 1.329 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.433 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -118.32 112.71 20.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.341 . . . . 0.0 110.788 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 47' ' ' VAL . 61.8 t -69.72 156.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -148.78 160.25 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 120.836 0.35 . . . . 0.0 111.195 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 46.3 m-85 -132.81 103.48 6.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 62' ' ' GLY . 40.4 t -71.33 133.09 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.777 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.11 -25.3 11.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.931 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -159.87 160.91 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 110.984 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.09 89.68 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.88 128.1 35.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -126.65 -167.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.031 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.86 12.54 54.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.603 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 166.48 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.93 23.75 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.824 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -52.2 -44.76 64.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.919 0.39 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.04 -15.61 57.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.543 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -118.51 88.23 2.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.379 . . . . 0.0 111.19 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.432 ' CZ2' ' HE2' ' A' ' 52' ' ' LYS . 12.7 m0 -83.47 152.08 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -97.35 125.89 8.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.259 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.36 -162.11 10.81 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.968 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.24 124.36 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.814 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.91 150.09 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.953 0.883 . . . . 0.0 110.962 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 1.5 pt20 -54.31 154.45 4.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.209 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.91 -78.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.58 179.72 3.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -113.95 32.31 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -118.55 108.52 15.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.29 -120.04 21.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.34 60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.115 0.483 . . . . 0.0 110.747 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.0 76.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.47 75.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.997 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.4 161.04 16.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -100.14 105.99 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 125.49 24.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.0 -175.63 16.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 16.9 m-85 -131.57 117.46 18.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.748 0.309 . . . . 0.0 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 41' ' ' ILE . 8.9 p90 -159.01 156.49 26.64 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.94 140.35 94.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.645 2.23 . . . . 0.0 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HB2' ' CE3' ' A' ' 61' ' ' TRP . 11.5 t -73.15 -26.91 61.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.012 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -48.42 -39.4 22.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.423 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 31' ' ' TYR . 30.1 mm -64.2 -32.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 27' ' ' ALA . 15.7 m -103.51 169.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 28' ' ' LEU . 8.1 ttt180 -130.79 106.39 8.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.1 mp0 -70.75 131.94 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.268 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.95 -48.37 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -103.14 153.22 20.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.339 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.726 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.1 p -138.04 149.81 46.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 0.0 111.773 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -151.34 38.06 0.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.8 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -88.07 104.84 7.63 Favored Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.48 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.875 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 73.3 Cg_endo -73.34 -21.15 20.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.406 2.071 . . . . 0.0 112.016 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.45 168.28 26.77 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.39 51.27 0.83 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.043 0.449 . . . . 0.0 110.31 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -95.37 140.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -77.5 150.82 34.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.828 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 t -145.03 115.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.983 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 113.57 2.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.2 t -78.78 163.24 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.84 -71.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -127.54 5.85 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.354 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -54.56 -23.5 17.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.723 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -135.58 75.57 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -83.46 130.98 35.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.24 100.05 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.5 p -60.09 125.43 23.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.763 0.315 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -106.01 120.79 42.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.77 151.35 49.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -147.21 144.46 28.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.785 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.15 140.62 29.3 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.148 0.975 . . . . 0.0 112.532 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.44 153.39 49.77 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.166 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.874 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -68.7 67.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.168 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 0.6 OUTLIER 64.23 -177.75 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.79 80.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -170.09 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.799 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m 55.61 24.1 6.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -112.93 -30.9 6.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.132 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.17 145.44 88.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.028 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 143.95 24.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.681 2.254 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 23' ' ' SER . 2.1 tp -76.87 -49.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.564 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 24.1 m -168.74 -168.73 0.92 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.453 ' CE ' HG11 ' A' ' 46' ' ' VAL . 6.2 ttt -122.41 136.84 54.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.811 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -147.96 134.54 19.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.668 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 46' ' ' VAL . 26.6 t -101.95 152.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.288 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.85 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -62.7 127.12 29.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 86' ' ' ARG . 4.0 tp -91.07 1.24 57.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.272 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 13.7 pt20 166.09 174.92 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.083 0.468 . . . . 0.0 110.972 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 35.9 t0 -73.66 139.3 45.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.826 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.76 ' HD2' HD13 ' A' ' 41' ' ' ILE . 24.6 t80 -161.03 87.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.183 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.402 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.08 137.56 57.76 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.8 151.64 0.19 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.125 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 -39.66 4.44 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.607 2.205 . . . . 0.0 112.306 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -175.48 173.31 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 64.4 m 61.31 22.8 13.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 53.14 51.99 14.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.906 0.384 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.91 -165.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 65' ' ' VAL . 5.0 tt -91.2 114.21 26.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 41' ' ' ILE . 2.6 t -79.56 169.99 17.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.109 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 31' ' ' TYR . 3.4 mp -132.01 102.83 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.848 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -99.1 149.24 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.439 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 mmm180 -44.01 162.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.88 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.91 40.04 5.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.416 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -123.4 109.41 13.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.7 0.286 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 26' ' ' VAL . 60.2 t -69.48 156.02 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.44 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.3 t -147.22 166.67 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 120.808 0.337 . . . . 0.0 111.354 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 24' ' ' MET . 5.5 m-85 -137.3 99.79 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 62' ' ' GLY . 31.0 t -69.94 132.09 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -110.79 -26.27 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.999 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 m -146.94 147.42 30.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -138.07 87.93 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' A' ' 100' ' ' THR . 10.1 tt -75.04 125.85 29.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.756 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -119.77 -161.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.41 -61.28 3.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.07 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.69 14.46 3.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.002 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.72 24.67 0.35 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.712 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -50.56 -29.82 11.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.935 0.398 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -0.78 24.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.826 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.89 89.67 3.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.981 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 52' ' ' LYS . 21.7 m0 -98.16 128.22 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -83.28 140.51 19.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.26 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.44 -158.19 10.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.826 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.26 126.15 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.777 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -74.05 150.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.911 0.862 . . . . 0.0 111.023 -179.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -56.82 155.91 7.25 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.85 -159.94 23.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.547 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -104.96 174.63 5.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -143.44 30.83 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -171.05 118.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.23 77.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.28 60.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.097 0.475 . . . . 0.0 110.637 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 1.1 mp -84.07 128.71 34.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.916 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 173.57 74.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.6 158.74 43.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.16 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -160.17 149.33 17.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.768 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tt -75.44 115.54 15.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.2 12.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -119.07 123.68 45.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 41' ' ' ILE . 49.2 p90 -159.05 158.22 28.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.81 135.8 35.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.605 2.203 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 17.9 p -74.1 -31.25 62.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.4 p -48.47 -30.14 4.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 31' ' ' TYR . 8.3 mm -63.53 -36.95 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.211 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 27' ' ' ALA . 30.2 m -110.38 154.03 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.095 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' LEU . 16.2 ttt180 -110.28 114.47 27.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.582 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 5.1 pt-20 -76.81 126.86 31.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -47.47 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 25.9 tt0 -101.39 150.21 23.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.507 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.557 HG22 ' OG ' ' A' ' 23' ' ' SER . 12.2 p -138.16 149.59 46.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.183 0.516 . . . . 0.0 111.56 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.1 tt -151.71 26.89 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.54 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 22' ' ' ILE . 25.7 ttpt -59.23 108.72 1.46 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.58 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.874 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 87.2 Cg_endo -85.03 -44.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.631 2.221 . . . . 0.0 112.15 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -126.16 166.38 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.266 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -151.03 49.05 0.85 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.838 0.352 . . . . 0.0 110.736 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 4.0 t -87.86 138.43 19.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.97 149.84 41.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.258 0.552 . . . . 0.0 111.142 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' LYS . 10.5 t -145.1 105.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.914 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 97.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.163 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 53' ' ' LEU . 11.3 t -79.04 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.58 172.86 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.1 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -78.75 -73.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.3 -23.7 9.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.928 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.36 81.19 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 t80 60.84 162.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.04 179.61 7.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 60.97 112.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.912 0.387 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.31 112.16 10.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.18 133.58 17.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.723 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.5 ttmt -143.8 132.6 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.06 140.67 29.26 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.221 1.01 . . . . 0.0 112.702 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -143.92 167.79 21.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.432 -1.713 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -66.2 75.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.917 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' OD1' HG21 ' A' ' 96' ' ' VAL . 2.7 t0 63.81 -168.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -75.31 62.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.885 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.13 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t 58.33 39.81 25.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -68.6 -62.61 1.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.985 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.45 136.76 59.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.1 168.44 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.476 2.118 . . . . 0.0 112.336 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.5 tp -80.08 -45.99 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.278 0.561 . . . . 0.0 111.023 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 90' ' ' THR . 94.3 p -173.88 -167.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.647 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.459 ' CE ' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -124.14 138.0 54.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.852 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.16 134.21 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 111.671 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -100.42 150.16 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -66.43 123.96 21.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.288 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -90.97 3.43 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 164.89 168.3 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.84 0.456 . . . . 0.0 111.078 179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.35 146.37 54.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.484 ' CB ' HG21 ' A' ' 84' ' ' ILE . 41.8 t80 -161.06 88.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.446 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 21.9 mtm -65.19 132.98 50.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.23 161.2 0.11 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.126 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.7 Cg_endo -70.83 -46.85 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.245 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 t0 179.99 -166.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 m 63.57 -91.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.48 33.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.784 0.326 . . . . 0.0 111.052 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.879 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 6.2 m-85 -63.96 -177.79 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.66 124.65 49.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.28 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.8 t -81.76 155.06 25.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.231 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' PHE . 60.4 mt -109.51 146.16 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.511 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.08 148.34 46.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 111.337 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.74 158.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.781 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.73 47.54 13.28 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.232 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -134.04 109.08 8.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 26' ' ' VAL . 79.4 t -69.93 157.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.612 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 65' ' ' VAL . 2.2 t -149.74 151.33 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 24' ' ' MET . 4.8 m-85 -115.41 100.61 8.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.697 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' HB ' HG22 ' A' ' 22' ' ' ILE . 43.2 t -69.86 118.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 110.827 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.651 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -94.9 -32.48 13.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.35 155.1 36.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 111.097 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' CH2' ' A' ' 61' ' ' TRP . 4.3 mtmt -136.24 81.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.792 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.64 121.51 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HA ' ' CA ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -114.76 -172.18 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.98 -61.2 3.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.95 -0.11 11.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.472 0.177 . . . . 0.0 111.465 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.64 22.66 0.63 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.065 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' CA ' ' HA ' ' A' ' 54' ' ' LYS . 30.4 ttt-85 -50.56 -44.75 56.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.966 0.412 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.38 -15.29 47.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.642 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 94.53 4.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.977 0.418 . . . . 0.0 110.51 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 37.2 m0 -80.75 179.72 7.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.682 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.77 134.22 7.55 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.47 -153.14 8.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.875 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -157.37 137.9 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.1 147.64 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-O 121.814 0.816 . . . . 0.0 110.929 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.83 142.01 20.12 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.308 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.51 28.23 2.57 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.404 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.0 87.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -65.43 162.67 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -61.48 131.84 51.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.15 -103.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.492 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 79.01 55.71 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.251 0.548 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.78 97.1 5.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.06 74.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.182 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.69 118.14 35.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.049 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 150.57 16.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.79 HD12 ' OG ' ' A' ' 64' ' ' SER . 2.0 tp -63.49 118.36 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.13 170.25 14.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.293 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.3 m-85 -110.22 128.53 55.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.695 ' CD2' HD11 ' A' ' 41' ' ' ILE . 48.4 p90 -159.2 145.32 12.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.577 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HB2' HD12 ' A' ' 84' ' ' ILE . 32.4 Cg_exo -54.83 165.27 2.7 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.799 2.333 . . . . 0.0 112.145 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 61' ' ' TRP . 37.0 p -91.82 -27.64 17.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.0 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.2 p -51.84 -58.01 7.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 81' ' ' PRO . 1.9 mp -50.7 -35.2 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 80' ' ' PHE . 26.8 m -98.45 173.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 107.02 5.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.0 OUTLIER -74.34 127.37 32.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.266 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -119.19 -48.46 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -99.98 152.71 19.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.439 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 23' ' ' SER . 3.0 p -138.11 149.78 46.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.175 0.512 . . . . 0.0 111.744 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 tt -153.35 36.5 0.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.771 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 21.7 ttpt -86.11 108.53 17.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.113 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 85.7 Cg_endo -80.26 -37.96 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.516 2.144 . . . . 0.0 111.841 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -122.76 167.2 15.1 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.35 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -151.13 49.58 0.84 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.941 0.401 . . . . 0.0 110.777 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.444 HG21 ' OD1' ' A' ' 15' ' ' ASP . 10.5 t -94.99 141.11 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -73.4 153.97 40.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.086 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.2 t -145.15 106.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.822 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 119.69 8.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 65.9 m -85.8 123.01 30.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.55 37.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.86 -59.14 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.47 -24.02 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.809 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 t70 61.76 85.06 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.978 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -104.82 83.34 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.39 134.01 21.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.89 161.31 6.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.92 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.09 66.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -113.65 159.65 19.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.722 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 98' ' ' VAL . 12.1 pttt -146.13 150.29 35.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.2 mp -88.26 143.01 27.28 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.146 0.974 . . . . 0.0 112.478 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.7 m -140.98 155.68 46.18 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.161 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.96 82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . 1.3 m-20 59.8 -175.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -69.22 69.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -170.09 -51.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t 60.69 38.99 18.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -84.53 -43.12 14.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -92.35 146.7 33.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.35 179.08 4.84 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.535 2.157 . . . . 0.0 112.158 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 23' ' ' SER . 1.0 OUTLIER -88.53 -47.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.008 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 90' ' ' THR . 93.1 p -175.14 -168.53 0.34 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.877 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 1.5 tmt? -126.38 136.87 53.24 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.73 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -146.63 140.61 26.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.133 0.492 . . . . 0.0 111.81 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -100.08 150.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.281 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -59.48 124.94 21.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -88.01 -3.37 58.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.23 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.7 OUTLIER 165.81 171.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.1 0.476 . . . . 0.0 111.338 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 28.8 t0 -69.5 134.71 49.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 84' ' ' ILE . 31.6 t80 -161.16 93.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.4 OUTLIER -65.0 144.44 57.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.144 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -38.53 149.13 0.23 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.048 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.74 -30.09 12.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.692 2.261 . . . . 0.0 112.662 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -179.17 168.2 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 57.62 -152.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -95.57 37.62 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.846 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.802 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 -56.62 -175.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.903 0.383 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.945 HD21 HG22 ' A' ' 65' ' ' VAL . 15.9 tp -111.65 120.91 43.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.4 t -80.11 170.09 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.513 HG22 ' HB1' ' A' ' 27' ' ' ALA . 3.1 mp -133.21 112.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.682 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 12.6 t-160 -105.96 147.41 28.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.366 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.0 OUTLIER -44.41 154.91 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.722 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.48 47.79 28.63 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.285 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.514 HE21 HG11 ' A' ' 65' ' ' VAL . 7.8 tt0 -134.05 111.22 10.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.731 0.3 . . . . 0.0 110.71 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 26' ' ' VAL . 57.4 t -69.68 155.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.84 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.04 148.9 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 120.855 0.36 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG22 ' A' ' 22' ' ' ILE . 21.8 t -70.01 135.86 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.064 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -109.51 -22.48 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.09 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -156.73 166.47 33.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' HG3' ' CE2' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -134.56 81.93 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.58 127.92 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -132.18 -162.02 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.93 -58.71 4.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.93 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -11.05 13.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.654 0.264 . . . . 0.0 110.95 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' PHE . . . -169.99 73.9 0.11 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.568 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.81 -41.3 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.736 0.303 . . . . 0.0 111.371 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.74 HD13 ' HG3' ' A' ' 81' ' ' PRO . 2.5 pp -61.56 -25.73 67.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.825 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -67.33 72.86 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.158 0.504 . . . . 0.0 110.879 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.441 ' CE2' ' HG3' ' A' ' 52' ' ' LYS . 11.7 m0 -81.85 121.8 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.928 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.66 121.01 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.25 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -149.32 -158.68 8.21 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.843 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.606 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.21 132.13 8.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.945 HG22 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.44 145.0 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 CA-C-O 121.727 0.775 . . . . 0.0 110.787 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.92 158.13 1.49 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.049 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.72 -179.78 43.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.539 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.3 -49.36 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.46 162.0 13.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -102.31 140.92 35.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.94 42.82 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -177.77 59.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -67.22 176.7 2.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.61 85.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 152.5 26.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 96.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -59.93 130.36 46.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.06 157.52 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.669 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -115.43 121.45 42.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 41' ' ' ILE . 2.7 p90 -159.18 164.84 19.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.195 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HG3' HD13 ' A' ' 59' ' ' LEU . 75.6 Cg_exo -49.7 125.67 14.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.713 2.275 . . . . 0.0 112.289 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 0.9 OUTLIER -64.63 -30.23 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -49.27 -29.91 6.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.415 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 31' ' ' TYR . 27.8 mm -63.19 -26.62 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.443 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 27' ' ' ALA . 36.0 m -124.49 146.2 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -99.6 117.79 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.691 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 17.1 pt-20 -81.85 125.06 30.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -111.34 -48.11 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.217 0.532 . . . . 0.0 110.723 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 0.4 OUTLIER -102.63 151.97 21.74 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.362 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 23' ' ' SER . 2.9 p -137.32 149.7 47.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.172 0.511 . . . . 0.0 111.831 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.445 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -150.67 39.72 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.566 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -92.0 105.14 12.56 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.779 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 90.0 Cg_endo -81.2 -39.56 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.746 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.89 167.38 15.18 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.148 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.96 49.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.975 0.417 . . . . 0.0 111.002 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t -93.57 140.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.605 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.33 153.1 40.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.0 t -145.16 106.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.937 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 97.89 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.94 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 t -79.04 148.37 32.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -178.76 37.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -129.2 -45.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -53.63 -23.95 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.786 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.66 94.17 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -100.17 129.95 46.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.69 171.99 14.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -174.88 92.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.828 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -103.15 112.04 24.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.16 157.0 46.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.831 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 98' ' ' VAL . 4.7 ttmt -148.45 140.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.26 140.68 29.23 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.182 0.991 . . . . 0.0 112.283 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.88 153.92 33.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.099 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -79.26 54.6 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.311 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 162.35 -172.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.565 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -53.81 4.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.08 -3.95 44.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.41 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.3 t 64.62 84.24 0.15 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -169.29 41.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -142.46 158.67 60.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 20' ' ' HIS . 66.6 Cg_endo -74.26 158.76 44.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.681 2.254 . . . . 0.0 112.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -106.14 -45.56 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.183 0.516 . . . . 0.0 110.947 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.496 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 60.7 p 178.86 -169.06 0.09 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.223 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.512 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 8.2 ttp -135.57 135.66 40.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.77 144.98 35.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 111.546 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 46' ' ' VAL . 27.3 t -101.78 151.93 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.209 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.846 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.58 122.41 17.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 29' ' ' GLN . 4.1 tp -86.29 0.31 54.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.221 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' CG ' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 166.38 169.8 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.768 0.427 . . . . 0.0 111.257 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' HIS . 9.9 t0 -72.0 146.21 47.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.852 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' HD2' HD12 ' A' ' 41' ' ' ILE . 32.6 t80 -161.05 88.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.233 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 3.9 ptm -65.47 120.91 13.72 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -39.36 159.4 0.11 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.12 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 37.8 Cg_endo -66.24 -43.3 8.79 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.53 2.153 . . . . 0.0 112.281 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.2 -173.87 0.47 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.72 28.44 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 43.15 39.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.668 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -169.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.592 HD11 HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -91.12 103.47 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.6 t -75.19 165.75 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 80' ' ' PHE . 33.4 mt -114.54 145.81 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 2.0 t60 -139.81 145.08 37.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 111.267 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -44.4 157.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.819 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.68 42.95 11.08 Favored Glycine 0 CA--C 1.518 0.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.454 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -127.16 111.79 14.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.623 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 47' ' ' VAL . 78.1 t -69.69 158.95 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.589 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 65' ' ' VAL . 1.1 t -149.67 161.0 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.065 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 24' ' ' MET . 4.6 m-85 -131.98 100.76 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.43 133.25 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -104.52 -25.28 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.818 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -164.74 166.96 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.04 90.71 2.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.029 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.44 121.9 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.744 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 11.2 pttt -123.28 -166.7 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.44 -60.98 2.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.057 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.43 9.71 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.496 0.188 . . . . 0.0 111.315 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.13 36.99 0.18 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.063 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -50.5 -35.75 30.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -3.77 32.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.79 87.29 2.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.904 0.383 . . . . 0.0 110.955 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -87.73 146.21 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.11 126.16 8.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.464 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.542 ' O ' HD23 ' A' ' 77' ' ' LEU . . . -153.67 -156.49 7.65 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.888 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.38 125.86 5.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.819 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -73.84 151.18 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.921 0.867 . . . . 0.0 110.956 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.96 150.17 21.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.73 107.36 0.32 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.439 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -105.73 -55.05 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.52 121.11 27.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.51 155.87 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 72' ' ' ASP . . . -139.86 35.59 1.91 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 54.2 m-20 74.07 53.75 0.1 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.41 0.624 . . . . 0.0 110.283 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.1 tp 55.86 110.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.371 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 178.84 84.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.029 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -168.51 132.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -164.54 148.87 9.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -60.98 131.44 50.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.31 170.93 13.86 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -125.08 113.75 18.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 41' ' ' ILE . 10.8 p90 -159.18 155.52 24.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 84' ' ' ILE . 9.9 Cg_endo -53.56 119.43 6.2 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.678 2.252 . . . . 0.0 112.097 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 81.5 p -66.13 -14.75 62.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.461 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -47.2 -47.75 24.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 111.553 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 81' ' ' PRO . 2.0 mp -56.06 -28.05 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.846 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.4 m -106.35 152.55 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.817 0.342 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttm105 -115.4 117.91 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 2.2 mt-10 -71.62 141.12 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.04 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.19 -44.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 48.2 tt0 -104.67 83.97 2.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.806 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.9 p -86.93 149.55 24.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.172 0.51 . . . . 0.0 111.561 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.74 26.21 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.61 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -54.19 106.75 0.71 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 93.3 Cg_endo -83.23 -42.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.72 2.28 . . . . 0.0 112.258 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' ALA . . . -127.8 170.16 19.37 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 pttt -152.11 51.08 0.79 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.852 0.358 . . . . 0.0 110.565 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 3.6 t -89.9 137.33 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.9 153.69 39.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.961 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' LYS . 21.8 t -145.06 99.73 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.867 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.88 87.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.91 151.15 31.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.99 145.59 31.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -46.16 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -54.47 -22.6 13.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.837 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.95 -52.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -103.54 117.57 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -151.55 111.27 4.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 123.58 17.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.855 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -105.22 103.99 13.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.6 155.01 42.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 153.08 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 95' ' ' LYS . 1.1 mp -88.32 139.31 30.62 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.24 1.019 . . . . 0.0 112.704 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.48 149.35 44.0 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.393 -1.731 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -72.75 60.74 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.54 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.2 169.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 55.63 -152.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.45 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 43.46 1.14 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 m 59.2 33.53 22.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.27 -30.26 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -85.34 149.62 52.62 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.63 -167.55 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.611 2.207 . . . . 0.0 112.423 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 23' ' ' SER . 2.1 mm -121.22 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.201 0.524 . . . . 0.0 111.149 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 22' ' ' ILE . 14.5 m -162.42 -167.25 1.54 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.739 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.506 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 3.5 ttp -130.75 131.94 45.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.867 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -140.95 137.9 33.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 0.0 111.518 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 46' ' ' VAL . 23.6 t -97.82 151.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.858 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -65.4 120.02 12.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.2 tt -82.87 -1.85 53.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.547 ' HG3' HD11 ' A' ' 84' ' ' ILE . 12.0 pt20 167.45 174.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.949 0.404 . . . . 0.0 110.898 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.74 145.79 44.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 84' ' ' ILE . 32.8 t80 -161.17 85.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.014 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.453 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.3 78.71 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.203 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -38.74 99.73 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.171 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.81 86.43 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.596 2.197 . . . . 0.0 112.356 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -169.5 85.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.974 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 m 58.19 36.64 25.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 60.33 42.85 14.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -169.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 65' ' ' VAL . 6.7 tt -83.32 101.32 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 1.2 t -71.92 169.97 14.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.186 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.505 HG22 ' HB1' ' A' ' 27' ' ' ALA . 30.4 mm -123.21 142.0 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -133.71 145.65 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 1.4 mmm180 -44.69 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.129 0.49 . . . . 0.0 111.788 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 43.85 46.65 7.65 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.29 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -130.65 111.49 12.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.371 . . . . 0.0 110.766 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 47' ' ' VAL . 59.2 t -69.89 154.91 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.855 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 65' ' ' VAL . 3.4 t -149.97 150.82 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 35.9 m-85 -119.31 118.11 30.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.728 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.9 t -69.99 133.9 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -26.26 8.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.98 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.33 157.15 22.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.076 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 61' ' ' TRP . 0.5 OUTLIER -138.16 125.79 22.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 53' ' ' LEU . 10.3 tt -117.2 125.29 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -127.05 -160.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.978 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.69 -59.14 4.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.104 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 18.24 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.92 36.17 0.18 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.679 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -34.28 26.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -7.81 42.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.827 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.78 85.04 2.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 111.131 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 52' ' ' LYS . 6.4 m0 -100.7 141.7 33.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 132.8 11.33 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.54 -169.02 21.52 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.855 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -157.24 129.29 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -74.42 150.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.836 0.826 . . . . 0.0 110.696 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -55.63 115.34 2.28 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.041 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.43 94.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.03 117.9 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -170.42 166.96 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.55 30.29 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -157.17 95.72 0.15 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.402 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 79.04 55.84 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.317 0.579 . . . . 0.0 110.364 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 74' ' ' ALA . 7.6 tt -80.33 153.88 28.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 73' ' ' LEU . . . 177.23 83.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.36 107.24 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 94.89 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 77' ' ' LEU . 4.5 pp -60.1 139.98 57.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.035 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.34 177.27 20.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -106.01 128.34 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -159.1 154.69 22.66 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.9 Cg_endo -59.15 103.73 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.602 2.201 . . . . 0.0 112.064 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -25.61 10.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -49.52 -28.15 5.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.191 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 81' ' ' PRO . 4.9 tp -71.04 -30.39 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' A' ' 27' ' ' ALA . 27.3 m -106.37 154.2 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -112.64 117.48 32.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.721 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 1.3 mt-10 -70.58 136.93 49.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.61 -45.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.282 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.2 tp-100 -105.05 84.07 2.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.853 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 23' ' ' SER . 8.9 p -85.14 149.45 25.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 0.0 111.571 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.48 27.31 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.475 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -54.56 107.29 0.82 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.52 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 86.5 Cg_endo -83.79 -27.05 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.553 2.169 . . . . 0.0 112.135 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -144.64 162.59 28.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.19 48.9 0.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.947 0.403 . . . . 0.0 110.552 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.62 137.47 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.917 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.4 141.61 43.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.39 113.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.45 101.13 8.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.038 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.8 t -79.11 179.32 7.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -103.35 93.94 5.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.31 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.56 -162.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.108 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -57.9 -15.18 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t70 73.51 4.03 4.69 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 175.43 122.85 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.799 0.333 . . . . 0.0 110.749 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -93.7 129.44 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 96.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.876 ' HB1' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.809 0.338 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.6 48.36 4.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -131.36 149.7 52.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -145.61 139.09 26.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.82 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -88.15 141.86 28.22 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.189 0.995 . . . . 0.0 112.763 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 m -146.77 163.87 34.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.045 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -60.53 84.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.995 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 61.04 -178.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.5 74.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -170.04 -53.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.6 t 59.67 31.6 20.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -90.5 -38.96 12.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -85.1 142.49 38.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.51 178.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.544 2.163 . . . . 0.0 112.294 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.8 tp -109.22 -47.86 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.271 0.557 . . . . 0.0 111.092 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 22' ' ' ILE . 77.2 p -179.4 -169.39 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.503 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.5 ttp -132.93 135.81 45.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.593 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . . . -143.68 141.81 30.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 111.957 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 46' ' ' VAL . 34.4 t -101.17 153.15 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.395 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.834 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -66.52 129.91 41.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.224 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -92.29 1.0 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.216 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.9 pt20 165.76 175.34 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.76 147.86 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.754 ' CG ' HD13 ' A' ' 84' ' ' ILE . 35.3 t80 -161.02 90.81 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 78.0 mtp -65.29 125.45 25.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -39.06 132.74 1.15 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.155 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -52.62 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.497 2.131 . . . . 0.0 112.233 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.51 -172.37 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.42 35.78 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 40.86 35.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.8 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 0.8 OUTLIER -60.77 -178.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.13 125.76 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 3.1 t -81.81 169.97 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 0.0 111.166 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD11 ' CG ' ' A' ' 80' ' ' PHE . 21.5 mt -124.15 147.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.348 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 150.29 47.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 7.3 mmm180 -46.82 160.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.652 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 45.0 49.53 9.24 Favored Glycine 0 CA--C 1.517 0.205 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.221 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.04 111.96 10.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.832 0.349 . . . . 0.0 110.886 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 26' ' ' VAL . 43.6 t -71.46 155.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 65' ' ' VAL . 2.4 t -146.73 148.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 120.852 0.358 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -114.89 99.75 7.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.94 129.57 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.28 -27.11 12.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.952 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -164.07 163.0 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.04 87.17 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.52 131.42 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -131.06 -163.67 1.35 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.34 -47.93 2.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.699 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.876 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 4.9 ptm180 -152.5 22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.706 0.288 . . . . 0.0 110.689 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.5 26.14 0.17 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.76 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -49.48 -31.0 9.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.901 0.381 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.11 -10.8 59.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.826 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.71 91.43 3.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.033 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 82' ' ' SER . 22.6 m0 -80.29 -178.02 6.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.12 126.18 4.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.188 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.87 -156.72 8.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.714 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -157.37 128.69 6.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.7 147.38 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-O 121.909 0.862 . . . . 0.0 110.918 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.31 157.94 17.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.74 51.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.64 103.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.357 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -163.12 133.19 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.8 137.43 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.96 34.57 17.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -179.82 60.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.2 mp -93.31 119.21 32.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 176.59 95.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.98 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.47 146.45 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -149.58 138.11 20.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.97 133.28 47.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -122.54 147.13 16.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.456 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -113.72 114.66 26.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.92 ' CG ' HD11 ' A' ' 41' ' ' ILE . 8.8 p90 -159.04 156.13 25.78 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.17 130.5 38.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.526 2.151 . . . . 0.0 112.235 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB3' ' CE3' ' A' ' 61' ' ' TRP . 94.0 p -58.22 -28.14 64.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.9 p -49.62 -32.37 12.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.754 HD13 ' CG ' ' A' ' 31' ' ' TYR . 33.3 mt -66.74 -34.47 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 27' ' ' ALA . 23.2 m -106.43 179.01 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.101 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.692 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -137.49 107.4 6.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 12.4 pt-20 -71.46 133.57 45.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.049 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.55 -44.99 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 10.0 tt0 -99.16 83.83 2.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 23' ' ' SER . 10.5 p -87.73 149.52 24.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.233 0.54 . . . . 0.0 111.459 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.2 tt -153.13 25.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 110.45 5.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 83.3 Cg_endo -81.26 -30.05 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 111.819 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 14' ' ' ALA . . . -132.17 165.85 23.44 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.168 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -151.02 48.94 0.85 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.935 0.398 . . . . 0.0 110.807 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 11.6 t -95.94 141.47 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.706 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 48.0 t0 -74.28 153.89 39.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.331 0.586 . . . . 0.0 111.115 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.3 t -145.31 115.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mptt -79.45 106.85 11.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.264 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.5 t -78.97 165.48 23.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -126.45 -71.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.231 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.26 -27.99 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.076 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -54.96 -21.2 10.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.886 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -50.21 -29.62 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.219 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.25 94.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -75.2 105.23 6.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.1 96.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB1' ' NE ' ' A' ' 10' ' ' ARG . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.359 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -118.31 82.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' NE ' ' HB1' ' A' ' 8' ' ' ALA . 1.2 mpt_? -127.52 162.03 27.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' VAL . 0.8 OUTLIER -145.62 149.92 35.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.78 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.664 HD13 ' CE ' ' A' ' 52' ' ' LYS . 1.1 mp -88.14 138.18 31.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.14 0.972 . . . . 0.0 112.413 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.0 t -130.94 165.09 23.89 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.492 -1.686 . . . . 0.0 111.209 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 93' ' ' PRO . . . -75.01 60.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.026 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.22 -165.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -16.66 61.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -69.76 -64.01 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.034 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m 60.17 30.53 19.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -34.94 10.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -97.49 146.44 31.39 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.41 175.52 9.28 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.567 2.178 . . . . 0.0 112.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 23' ' ' SER . 1.3 tp -74.99 -45.28 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.295 0.569 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.734 ' CB ' HG22 ' A' ' 90' ' ' THR . 68.7 p -177.99 -167.67 0.15 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.703 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.477 ' HB3' ' HB3' ' A' ' 89' ' ' GLN . 9.6 tmm? -126.6 129.43 48.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.717 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB2' ' CG ' ' A' ' 87' ' ' GLU . . . -141.14 143.17 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.071 0.462 . . . . 0.0 111.76 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 46' ' ' VAL . 22.0 t -98.97 150.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.31 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -64.51 121.91 15.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD13 ' HG3' ' A' ' 86' ' ' ARG . 28.9 tp -85.29 -2.31 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.522 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.9 pt20 168.63 174.37 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.97 0.414 . . . . 0.0 110.886 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.2 144.73 40.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.703 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CD2' HD13 ' A' ' 84' ' ' ILE . 30.0 t80 -161.01 91.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.87 0.367 . . . . 0.0 111.368 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.456 ' HA ' ' OG1' ' A' ' 40' ' ' THR . 0.0 OUTLIER -65.41 131.09 45.55 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -40.26 159.3 0.14 Allowed Pre-proline 0 N--CA 1.454 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.023 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 56.5 Cg_endo -71.15 -47.87 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.519 2.146 . . . . 0.0 112.411 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.96 -165.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.1 t 64.25 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.006 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.59 39.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.901 0.381 . . . . 0.0 111.046 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.761 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 79.0 m-85 -74.8 166.15 24.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD21 ' CG2' ' A' ' 65' ' ' VAL . 13.4 tp -87.21 126.98 35.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 32' ' ' MET . 2.8 t -81.38 170.04 16.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.301 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 80' ' ' PHE . 18.6 mm -120.18 143.2 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.421 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -136.67 144.31 43.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 29' ' ' GLN . 8.3 mmm180 -44.1 160.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.0 111.98 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 41.48 48.47 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -134.2 112.29 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.772 0.32 . . . . 0.0 110.921 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.634 HG22 HG22 ' A' ' 26' ' ' VAL . 59.7 t -70.0 154.54 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.637 HG22 HG12 ' A' ' 65' ' ' VAL . 2.6 t -150.22 150.85 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 24' ' ' MET . 94.9 m-85 -122.64 112.93 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' HG22 ' A' ' 22' ' ' ILE . 23.2 t -80.46 129.97 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -110.78 -27.24 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 143.45 50.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.967 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.664 ' CE ' HD13 ' A' ' 12' ' ' LEU . 8.9 ttpp -138.04 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.65 171.12 5.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' O ' HD23 ' A' ' 53' ' ' LEU . 3.6 pttt -150.02 -160.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.44 78.83 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.885 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 63.6 16.17 9.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.51 -0.56 1.8 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.032 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.431 ' O ' ' CD1' ' A' ' 61' ' ' TRP . 0.4 OUTLIER -49.72 -25.03 2.63 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 116.957 0.378 . . . . 0.0 111.437 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.35 0.67 13.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -121.08 88.52 2.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.893 0.378 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 82' ' ' SER . 14.3 m0 -89.14 125.28 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.878 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.75 107.13 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.18 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 49' ' ' VAL . . . -134.85 -157.16 7.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.082 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.582 ' C ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -157.37 135.3 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -74.32 146.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.852 0.834 . . . . 0.0 110.706 -179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -52.97 154.84 2.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.194 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.18 39.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.43 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -58.52 -176.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.367 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.1 t80 62.15 115.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.14 167.37 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.58 25.39 6.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.542 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 179.47 60.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 tp -70.73 115.91 10.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . 174.0 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.013 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.17 158.1 20.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' O ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -157.58 127.54 6.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 64' ' ' SER . 18.1 mt -70.58 154.53 41.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -152.45 148.2 18.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.464 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.441 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 4.3 m-85 -98.75 123.96 43.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.908 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 41' ' ' ILE . 28.9 p90 -159.08 145.36 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' HD11 ' A' ' 84' ' ' ILE . 58.3 Cg_exo -50.32 128.0 21.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.579 2.186 . . . . 0.0 112.301 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 61' ' ' TRP . 6.2 t -59.6 -32.32 70.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -49.04 -27.8 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.678 HD13 ' CD2' ' A' ' 31' ' ' TYR . 18.9 mt -68.71 -29.39 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA ' ' A' ' 27' ' ' ALA . 31.3 m -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.13 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 28' ' ' LEU . 13.0 mmt180 -99.79 111.28 23.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.596 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.613 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -77.95 131.11 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.21 -47.35 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.675 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' MET . 3.1 tt0 -103.94 150.49 24.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.524 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.734 HG22 ' CB ' ' A' ' 23' ' ' SER . 8.0 p -135.89 149.69 49.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.186 0.517 . . . . 0.0 111.559 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.1 32.86 1.0 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.49 108.64 26.25 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.62 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HG2' ' HB1' ' A' ' 14' ' ' ALA . 88.8 Cg_endo -82.87 -22.86 4.08 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.482 2.121 . . . . 0.0 111.564 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.58 164.14 26.04 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.119 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.643 ' O ' HD23 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.21 49.76 0.84 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.062 0.458 . . . . 0.0 110.592 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 t -90.54 143.25 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.97 147.36 38.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' LYS . 5.1 t -145.13 118.12 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.968 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 125.17 25.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.1 t -78.88 158.73 28.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.049 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.7 -178.53 7.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -59.44 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -53.64 -23.62 11.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.802 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.52 65.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -88.58 98.0 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -134.09 167.57 20.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.04 118.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.89 -179.969 . . . . . . . . 0 0 . 1 stop_ save_